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ABSTRACT 
Hypertension and heart failure are intimately related with the incidence of heart failure among 
hypertensive subjects between 1% and 2% per year. Structural and functional myocardial 
abnormalities identified in hypertensive patients contribute to the progression of myocardial 
dysfunction.  Systolic abnormalities in hypertension begin to develop in the early stages of the 
disease despite normal left ventricular (LV) ejection fraction (EF) and contribute to the progressive 
deterioration of LV systolic performance. However, these systolic abnormalities are initially not 
detectable by conventional echocardiographic methods. Speckle tracking echocardiography (STE) 
is a sensitive quantitative technique for assessing LV function. LV twist is an important 
contributing factor to the systolic function of the LV in health and disease and may be a better 
index of systolic function than ejection fraction (EF) in hypertensive patients (HTP).  
 
The remodelling process of the left ventricle in hypertension entails a complex interplay between 
myocyte hypertrophy and dysfunction, with qualitative changes in the extracellular matrix 
contributing to progressive dysfunction. Adverse LV remodeling in HTP is associated with an 
imbalance in collagen degradation and may contribute to the remodelling phenotype and systolic 
dysfunction in hypertension. Increased matrix metalloproteinase-1 (MMP1) levels contribute to 
development of LV dilatation and failure with higher levels of MMP1 in the myocardium of 
hypertensive patients with low EF than those with normal EF.  
 
Hypertension can cause systolic dysfunction as a consequence of adverse remodelling and LV 
hypertrophy, but given the multitude of factors involved in LV decompensation mediated by 
mechanical, neurohormonal and cytokine routes, the exact mechanisms that contribute to the 
adverse remodelling and EF deterioration are not fully elucidated. LV twist may be a contributing 
factor to systolic dysfunction independent of other factors, thus, a focus on abnormalities in the 
cardiac mechanics of twist in the left ventricle may be helpful in understanding the pathogenesis 
behind the transition from compensated to decompensated heart failure. Furthermore, the changes 
in the extracellular matrix may account for the varying morphology, EF and LV twist in HTP.  
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The purpose of this thesis was to 1) determine LV twist in healthy adults of different age groups 
(n=127), 2) evaluate LV twist changes in African HTP with low (EF<50%) and preserved EF (EF ≥ 
50%) (n=82) and 3) examine the relationship between LV twist and biomarkers of collagen 
degradation in HTP with preserved and low EF.  
 
Parasternal short-axis images of three consecutive end-expiratory cardiac cycles at LV basal and 
apical levels were obtained. Apical rotation (AR) and basal rotation (BR) during ejection and 
instantaneous LV peak systolic twist (net twist, defined as maximal value of instantaneous AR 
minus BR) were measured. 127 normal subjects were divided into four age groups: 20-29 (n=34); 
30-39 (n=33); 40-49 (n=29); and 50-65 (n=31) years.  LV twist and markers of collagen turnover 
(serum concentrations of matrix metalloproteinase -1 (MMP1), tissue inhibitor of MMP1 (TIMP1) 
and ratio of MMP1:TIMP1) were measured in 82 hypertensive patients, 41 with EF < 50% 
(HTLEF) and 41 with EF ≥ 50% (HTNEF). Rigid body rotation (RBR) was defined as AR and BR 
occurring in the same direction. Serum biomarkers were log transformed before analysis. 
 
LV twist increased with age in normal subjects. Multivariate linear regression analysis showed age 
as the main predictor of net LV twist (R
2
=0.82, P<0.0001) in normal subjects. Net LV twist was 
lower in HTLEF compared with HTNEF (3.34 + 1.10 vs. 11.70 + 0.67, p < 0.0001). Of 41 HTLEF 
patients, 28 (68%) had normal twist pattern while 13 (32%) exhibited RBR. The subgroup with 
RBR showed greater LV dysfunction (EF: 27.9±5.8% vs. 35±7.5%; p=0.005) and more spherical 
LV geometry (p=0.0009) compared with those who had normal pattern of twist. Log TIMP1, Log 
MMP1 and Log MMP1:TIMP1 ratio levels were higher in HTLEF compared with HTNEF (12.32 
± 0.25 vs. 11.81 ± 0.13, p<0.0001; 9.08 ± 0.32 vs. 8.00 ± 0.18, p<0.0001; -3.25 ± 0.30 vs. -3.81 ± 
0.18, p<0.0001; respectively). There was an inverse correlation between Log MMP1:TIMP1 and 
net LV twist after adjusting for EF (r = -0.41, p <0.0001).  
 
This study established normative data and patterns for myocardial deformation (strain and LV 
twist) in a normal black-African adult population across different age groups and can be used as a 
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baseline for future studies. Age was the major determinant of increased LV twist in a normal black 
population. LV twist may be a compensatory mechanism to preserve EF and maintain normal 
systolic function with advancing age and in hypertension. LV twist varies with the degree of 
remodeling and systolic function in hypertension. RBR represents a novel assessment of more 
severe LV remodeling and LV systolic dysfunction in hypertensive patients. Alterations in collagen 
turnover not only accompanies more adverse remodelling but also contributes to LV twist 
differences observed between HTLEF and HTNEF patients. The inverse relation between LV twist 
and loss of myocardial collagen scaffolding suggests that integrity of the extracellular matrix may 
play an important role in preservation of LV twist.  These findings highlight the value of LV twist 
as a sensitive global parameter of LV systolic myocardial performance. Longitudinal studies 
assessing LV twist may provide significant value in clinical practice as an early marker for risk 
stratification in hypertensive patients who may benefit from aggressive medical therapy to prevent 
LV remodelling and heart failure. 
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NOMENCLATURE 
 
Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACE/ARB)  
Apical rotation (AR) 
Basal rotation (BR) 
Basal anterior (BA) 
Basal anterolateral (BAL) 
Basal anteroseptal (BAS) 
Basal inferior (BI) 
Basal inferolateral (BIL) 
Basal inferoseptal (BIS) 
Blood pressure (BP) 
Circumferential strain (CS) 
Deceleration time (Decel time) 
End-diastolic diameter (EDD) 
End-diastolic volume (EDV) 
End-diastolic volume index (EDVI) 
Ejection fraction (EF) 
E` lateral wall velocity (E`L)  
E` medial wall velocity (E` M) 
End-systolic volume (ESV) 
End-systolic volume index (ESVI) 
Extracellular matrix (ECM) 
Heart failure (HF) 
Hypertensive patients (HTP) 
Hypertensive heart disease (HHD) 
Hypertensive patients with low ejection fraction (HTLEF) 
Hypertensive patients with normal ejection fraction (HTNEF) 
 
 
viii 
 
Interventricular septum end-diastolic diameter (IVSD) 
Left atrial volume index (LAVI) 
Left ventricular (LV) 
Left ventricular hypertrophy (LVH) 
Left ventricular posterior wall diameter (LVPWD)  
Left ventricular sphericity index (LVSPHI) 
Longitudinal strain (LS) 
Magnetic resonance imaging (MRI) 
Matrix metalloproteinases (MMPs)  
New York Heart Association (NYHA) 
Pulse pressure (PP) 
Radial strain (RS) 
Rigid body rotation (RBR) 
Speckle tracking echocardiography (STE) 
Subendocardial apical rotation (Subendo AR) 
Subepicardial apical rotation (Subepi AR) 
Subendocardial basal rotation (Subendo BR) 
Subepicardial basal rotation (Subepi BR) 
Tissue inhibitor of matrix metalloproteinases (TIMPs) 
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1.0 INTRODUCTION 
 
1.1 HYPERTENSIVE HEART DISEASE  
 
Hypertension is the commonest cardiovascular disease in black Africans (Steyn et  al . ,  2001) .  
In South Africa about 1/5 to 1/4 individuals of African ancestry have hypertension with a large 
proportion not at target blood pressure (BP) levels (Steyn et al., 2001, Steyn et al., 1996, Alberts et 
al., 2005). Hypertension is the most important risk factor for ischaemic heart disease, stroke, 
peripheral vascular disease, chronic renal disease and heart failure (HF) (Alberts et al., 2005, 
Mabuza, 2008). The increased prevalence of hypertension in the black community in South Africa 
seems to be associated with changes in lifestyle such as urbanisation, alcohol consumption, 
smoking, and obesity (Alberts et al., 2005). As a consequence of the high prevalence of 
hypertension there is an increased risk of cardiovascular diseases (Alberts et al., 2005) in rural 
communities and presumably in urban communities (Seedat, 1998, Connor et al., 2006). 
 
The identification of target organ damage such as left ventricular hypertrophy (LVH) is important 
for the prediction of cardiovascular risk (Williams B, 2004) with significant therapeutic and 
prognostic implications. LV (left ventricular) geometric patterns, regardless of categorization 
criteria, are reliable markers of cardiovascular risk (Cuspidi et al., 2010) with LVH associated with 
adverse outcomes. Furthermore, patients with concentric remodelling have been shown to have 
similarly poor outcomes to those with LV hypertrophy when compared to patients with normal LV 
geometry (Kizer et al., 2004). 
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Figure 1.1.1  Factors contributing to LVH in hypertension 
 
The response of the left ventricle to pressure overload is different in black patients, with a high 
prevalence and severity of concentric geometry as demonstrated in the Baragwanath Ambulatory 
Monitoring Study in hypertension (Sareli et al., 2001). In a large population-based cohort of treated 
hypertensive patients (HTP), black patients had higher mean LV mass index and relative wall 
thickness than Caucasian patients—differences that persisted after adjustment for conventional 
demographic and clinical risk factors (Kizer et al., 2004). Accordingly, the prevalence of LV 
hypertrophy and concentric geometry in black patients was twice that of whites (Kizer et al., 2004) 
independent of  clinical covariates, measures of systemic haemodynamics and vascular stiffness 
(Kizer et al., 2004).  In an African-American population, LVH as detected by echocardiography 
was a precursor of premature cardiovascular morbidity and mortality after adjusting for traditional 
risk factors (age, diabetes and smoking) including BP (Nunez et al., 2005). The jury is still out on 
the mechanisms (ethnic propensity or greater severity of hypertension) behind the genesis of LV 
remodelling in black patients (Kizer et al., 2004). Furthermore, the determinants of LV geometry 
[Fig. 1.1.1] and indeed the mechanism whereby altered geometry mediates increased risk is poorly 
defined. 
 
 
- 3 - 
 
Initially, LVH represents a compensatory response to pressure overload in hypertension (Drazner, 
2011, Drazner, 2005). However, over time and with continuing excessive load, a variety of changes 
occur in the structure, function, architecture, microcirculation and metabolism of the myocardium 
that collectively have been termed remodelling (Frohlich, 1999, Frohlich et al., 1992, Drazner, 
2011). Despite normal left ventricular ejection fraction (EF), decreases in systolic function have 
been identified in patients with concentric LV hypertrophy as measured by midwall shortening, 
implicating abnormal myocardial function proceeding to developing dilated cardiac failure.  
 
Although concentric LVH is associated with subtle abnormalities in systolic function, it has not 
been shown in longitudinal studies whether such patients subsequently develop ventricular dilation 
in the absence of coronary artery disease. Furthermore, LVH was also associated with a decrease in 
left ventricular EF, independent of conventional BP in HTP (Drazner et al., 2005). Therefore, it is 
important to assess accurately left ventricular systolic function in HTP with or without LVH using 
sensitive measures other than EF.   
 
1.1.1 HYPERTENSION INDUCED HEART FAILURE 
 
Hypertension is the leading cause of HF in black patients indicating an advanced and often 
irreversible degree of organ damage (Drazner, 2011, Drazner, 2005). Adverse remodelling and 
decreased myocardial contractile function contribute to hypertension induced heart failure. Based 
on published data, black patients have HF at an earlier age and more advanced left ventricular 
dysfunction with poorer functional class at the time of diagnosis. The precursor to decompensated 
HF is thought to primarily be LVH and not coronary artery disease (Yancy, 2003).  
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Figure 1.1.2  Factors contributing to hypertension induced heart failure 
 
The connection between hypertension and HF appears to represent a continuum of cardiovascular 
disease, initiated as hypertension reflecting primarily vascular endothelial dysfunction (or vascular 
remodeling), which then progresses to the clinical scenario of HF reflecting ventricular dysfunction 
(or ventricular remodeling) (Yancy, 2003). Thus, a predisposition toward ventricular remodeling 
and LVH may likewise contribute to a higher incidence of HF, which, when present, is a more 
malignant disease (Yancy, 2003). Although eccentric hypertrophy is a common precursor to 
reduced EF, concentric LV hypertrophy may also be important  in the deterioration to LV systolic 
dysfunctionand may allow refinement of phenotypic characterization of HTP (HTP) identifying 
risk factors for LV response to hypertension (Drazner, 2005) and likely progression to HF. 
However, there are no longitudinal studies documenting the transition from normal EF to low EF in 
the absence of coronary artery disease in HPT with LVH.  
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Traditionally, global systolic function is assessed by calculating EF using the Modified Simpsons 
biplane method (Lang et al., 2005).  LV EF is the most common clinically used echocardiographic 
parameter to quantify the severity of LV systolic dysfunction in patients with HF. However, EF 
describes LV systolic chamber function and does not always reflect global LV myocardial 
contractile performance or provide information about individual myocardial deformation 
components, which may have prognostic utility in hypertensive heart disease (HHD). Whereas wall 
stress remains difficult to measure, myocardial strain and LV twist may be measured using speckle 
tracking echocardiography (STE) to detect subclinical myocardial dysfunction in HHD (Kang et 
al., 2008, Narayanan et al., 2009, Mizuguchi et al., 2010b, Mizuguchi et al., 2009, Mizuguchi et al., 
2008, Mizuguchi et al., 2010a) as an adjunct to conventional echocardiographic parameters.  
 
1.2 SPECKLE TRACKING ECHOCARDIOGRAPHY 
 
1.2.1 STRAIN  
 
Strain imaging has emerged as a useful technique to estimate myocardial function and contractility 
(Hoffmann et al., 1996, D'hooge et al., 2000). Two-dimensional (2D) STE enables objective 
assessment of left ventricular function through the analysis of myocardial strain based on similar 
principles that are used in tagged magnetic resonance imaging (MRI). The measurement of strain 
by STE has been validated against sonomicrometry and MRI (Gilman et al., 2004). In a sub study, 
comparing STE with tagged MRI (the current gold standard for deformation analysis), strain 
measured by STE correlated well with that obtained by MRI  (Goffinet et al., 2009). 
 
2D strain utilizes natural acoustic markers for frame-to-frame tracking of myocardial motion by 
tracking speckles in an ultrasonic B mode image over numerous frames using specialized software 
(Marwick et al., 2009, Marwick, 2010, Marwick, 2006, Perk et al., 2007, Nesbitt et al., 2009). The 
speckles are the result of constructive and destructive interference of ultrasound, back-scattered 
from structures smaller than a wavelength of ultrasound (Mor-Avi et al., 2011). This gives each 
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small area a rather unique speckle pattern that remains relatively constant from one frame to the 
next (Mor-Avi et al., 2011). Therefore, a suitable pattern-matching algorithm can identify the 
frame-to-frame displacement of a speckle pattern, allowing myocardial motion to be followed in 
two dimensions (Mor-Avi et al., 2011).  
 
The appearance of these acoustic markers is considered to be relatively stable between subsequent 
image frames, so that a change in their position is assumed to follow tissue motion. Tracking is 
based on searching for the new location of the marker in the subsequent frame. Two dimensional 
strain and strain rate are then calculated from the displacement and rate of displacement of each 
marker, respectively. Since tracking is based on gray-scale B-mode images, it is in principle, angle-
independent and affords good temporal and spatial resolution. Strain is defined as a dimensionless 
index which is the ratio of final to initial length of a myocardial fibre (Nesbitt et al., 2009) 
[Fig.1.2.1.1]. Consequently, positive strain occurs if the segment length exceeds its original length, 
and negative strain exists if the segment length is shorter than its original length. Strain occurs in 
radial (narrowing or compression and widening or expansion), longitudinal (shortening and 
lengthening), and circumferential (tangential) directions [Fig. 1.2.1.2].  
 
 
Strain = Change in length (e) 
 Original length (Lo) 
 
 
 
Figure 1.2.1.1  Strain formula 
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Figure 1.2.1.2 A - Radial strain; B- Circumferential strain; C- Longitudinal strain 
 
The advent of 2D STE has allowed a comprehensive and quantitative assessment of left ventricular 
function (Mor-Avi et al., 2011). Over the past 5 years, numerous studies have demonstrated that 
impaired myocardial strain is an indicator of global and regional dysfunction in various cardiac 
conditions, although different speckle tracking software have been used (Mor-Avi et al., 2011). 
Data regarding accuracy, validity, and clinical application of STE are rapidly accumulating with 
low intra- and interobserver variability (Korinek et al., 2005, Amundsen et al., 2006, Buckberg et 
al., 2004). The clinical utility of these measurements has been demonstrated in a spectrum of 
cardiovascular pathophysiologies (Mor-Avi et al., 2011). The accuracy and rapid analysis of 2D 
STE converts this technique into a suitable method for objective assessment of myocardial function 
C 
A B 
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in clinical practice. As such, speckle tracking could potentially be used as a bedside tool to improve 
the assessment of the global and regional functional status of the myocardium. 
 
1.2.2 LEFT VENTRICULAR TWIST  
 
LV twist is defined as the wringing motion whereby the LV apex rotates with respect to the LV 
base about the LV long axis (Sengupta et al., 2008b). Viewed from the LV apex, systolic apical 
rotation (AR) is counterclockwise and basal rotation (BR) is clockwise (Sengupta et al., 2008b) 
[Fig. 1.2.2.1]. The main factors determining the degree of twist is the angle of motion and the 
amount of shortening of myocardial fibre which closely relates to the transmural fibre strain 
gradient between epicardial and endocardial myocardial fibres (Goffinet et al., 2009, Sengupta et 
al., 2008b, Sengupta et al., 2008a).  
 
 
 
 
 
TWIST = AR-BR (systole) 
Figure 1.2.2.1  Twist calculation 
 
LV myocardial fibre architecture is important for LV function (Sengupta et al., 2008b, Sengupta et 
al., 2008a). The left ventricle has a myocardial architecture, which is a transmural continuum 
APICAL ROTATION (AR) 
Counterclockwise 
(negative value) 
BASAL ROTATION (BR) 
Clockwise 
(positive value) 
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between two helical fibre arrangements, in which a subendocardial fibre wraps in a right-handed 
helix and a subepicardial fibre wraps in a left-handed helix (Sengupta et al., 2008b) [Fig. 1.2.2.2]. 
From the endocardium to the epicardium, the helix angle changes continuously (Sengupta et al., 
2008b) [Fig. 1.2.2.2]. LV twist is a result of equilibrium between torques caused by the oblique 
myofibres in the subepicardium and subendocardium (Alharthi et al., 2009) [Fig. 1.2.2.2].  
 
When both layers contract simultaneously, a larger radius of rotation for the outer epicardial layer 
results in epicardial fibres having a mechanical advantage in dominating the overall direction of 
rotation (Sengupta et al., 2008b) [Fig. 1.2.2.2]. Cardiac motion begins as a result of muscle fibre 
contraction in the base to narrow and elongate the ventricular chamber (McDonald, 1970, Ormiston 
et al., 1981). LV twist is greatest toward the apex to achieve maximal reduction in chamber volume 
(Bogaert and Rademakers, 2001) and may be explained by the fact that the right- and left-handed 
helical segments converge toward the apex to form the vortex of the double helical loop (Bogaert 
and Rademakers, 2001). 
 
Figure 1.2.2.2 Rotation of myocardial fibres at subendocardium and subepicardium      
(apical and basal levels) 
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LV twist may also be important to equalize transmural differences in sarcomere shortening, end-
systolic fibre stress, and contractile work during the ejection phase (Sengupta et al., 2007). The 
transmural spread of electrical activation results in sequential subendocardial-to-subepicardial fibre 
shortening (Sengupta et al., 2008a). The myocardium shortens along the entire transmural course, 
resulting in longitudinal and circumferential shortening of the left ventricle (Sengupta et al., 
2008a). Twist helps bring a uniform distribution of LV fibre stress and fibre shortening across the 
wall (Alharthi et al., 2009).  
 
To provide a framework for interpreting LV twist, Taber and colleagues (Taber et al., 1996) 
proposed a model of helical layer architecture on a one-layer cylinder composed of obliquely 
aligned muscle fibres embedded in an isotropic matrix. It has been demonstrated in a mathematical 
model that normal twist causes sarcomere shortening of 0.20 mm in the epicardium and 0.48 mm in 
the endocardium (Sengupta et al., 2007). Elimination of the twist, however, decreases epicardial 
shortening (0.10 mm) and increases endocardial shortening (0.55 mm) (Alharthi et al., 2009). Thus, 
disappearance of twist would increase endocardial stress and strain and increase oxygen demand, 
thereby reducing the efficiency of LV systolic function (Alharthi et al., 2009).  
 
Assessment of LV rotation and twist was initially obtained by MRI (Goffinet et al., 2009). STE has 
been validated as a reliable method to quantify LV twist. The potential clinical applications of LV 
twist indices are currently expanding. The magnitude of LV twist is determined by contractile 
force. Therefore, measurements of LV twist may be effective as a clinical index of local and global 
cardiac contractility, and could be used to estimate disease-related changes of myocardial function 
(Sengupta et al., 2008a, Sengupta et al., 2008b).  
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1.2.3 LV STRAIN IN HYPERTENSION 
 
In general, LV longitudinal strain (LS), which is predominantly governed by the subendocardial 
region, is the most vulnerable component of LV myocardial deformation in hypertension and 
therefore most sensitive to the presence of myocardial disease (Cho et al., 2006). The 
midmyocardial and epicardial function may remain relatively unaffected initially, hence 
circumferential strain (CS), radial strain, and LV twist may remain normal or show exaggerated 
compensation for preserving LV systolic performance (Cho et al., 2006). Two studies in the 
Japanese population using 2D STE have reported a decrease in some of the contractility indices 
(LS) in HTP with LVH as compared to normal controls (Amundsen et al., 2006, Mizuguchi et al., 
2010b).  
 
Furthermore, peak systolic strain was significantly reduced in patients with concentric hypertrophy 
and concentric remodelling when compared with patients with normal LV geometry (Hare et al., 
2008). These differences remained significant when corrected for age, systolic BP, wall stress, and 
baseline EF (Hare et al., 2008) indicating that there are abnormalities in baseline myocardial 
deformation that may be identified in patients with altered LV geometry. However, these findings 
were not predictive of the evolution of LV geometry (Hare et al., 2008). 
 
Plaksej showed in his study that LVH predominantly influences longitudinal and CS, but has a 
lesser impact on radial strain (RS) (Plaksej R, 2009). However, in an Asian population, all LV 
strain parameters were impaired in patients with hypertension and concentric hypertrophy 
(Mizuguchi et al., 2010b).  The definition of values for myocardial deformation in HTP are 
dependent on the vendors used and have only been validated in western populations (Minoshima et 
al., 2009, Narayanan et al., 2009, Quinones et al., 2002, Becker et al., 2006). Moreover, limited 
data exists on strain parameters in hypertensive patients with heart failure. In HTP, the reduction in 
myocardial function with evidence of LV hypertrophy and remodelling support further 
investigation of myocardial deformation and their role in reflecting the mechanisms linking altered 
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LV geometry with progression to decompensated LV systolic function (Hare et al., 2008, Drazner, 
2011).  
 
1.2.4 LV TWIST IN HEART FAILURE 
 
The dynamic interaction between subendocardial and subepicardial fibre helices in the left ventricle 
leads to a twisting deformation which plays an important role in optimizing LV EF (Sengupta et al., 
2008b). It has been shown experimentally as well as clinically that LV twist closely parallels 
changes in LV global ejection performance. In previous work, it has been shown that LV twist is of 
fundamental importance to systolic LV function, with LV twist showing a positive correlation with 
EF (Notomi et al., 2005). An acute transmural insult or progression of disease results in 
concomitant midmyocardial and subepicardial dysfunction, leading to a reduction in LV twist 
mechanics and a reduction in LV EF (Cho et al., 2006). 2D STE showed a significant correlation 
between peak systolic twist and EF (Popescu et al., 2009) consistent with magnetic resonance 
tagging methods (Kanzaki et al., 2006) where an impairment in peak LV systolic twist is 
proportional to the degree of global LV dysfunction. Recently, in a population of advanced HF 
patients a significant positive correlation between LV twist and EF (r = 0.53, p<0.001) was noted 
(Bertini et al., 2010). 
 
Recent studies have demonstrated the influence of cardiac shape on LV function, showing that LV 
myocardial fibre architecture is vital for an efficient LV performance. The geometry of the normal 
LV is ellipsoid with its long axis directed from apex to base (Streeter and Ramon, 1983, Streeter Jr 
et al., 1969). The size and shape of the LV changes, with an enlarged ventricle developing a 
spherical configuration (Popescu et al., 2009) resulting in significant changes in LV rotation. As 
demonstrated in a mathematical model  (Taber et al., 1996), LV dilation and thinning, present in 
dilated cardiomyopathy, equalizes the radii of the subepicardial and subendocardial layers; as a 
result, the mechanical advantage of the subepicardial myofibres (the major determinants of LV 
twist under physiological conditions) is reduced (Popescu et al., 2009).  
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Consequently, LV twist decreases with increasing cavity volume. Furthermore, the intrinsic 
processes causing a dilated cardiomyopathy result in myofibre disarray and alterations in myofibre 
angle (Popescu et al., 2009). These phenomena eventually lead to the loss of the physiological 
spiral architecture of the LV and to the impairment of LV twist (Popescu et al., 2009). Last but not 
least, slowed transmural fibre activation, related to fibrosis and remodelling of gap junctions, may 
delay the activation of the epicardial myofibres, determining an initial clockwise twist (because of 
the unopposed rotation of the endocardial myofibres) thereby impairing the peak LV twist (Adamu 
et al., 2009). 
 
As compared with ischemic heart disease patients, HF patients have a more pronounced 
impairment of LV rotational mechanics, irrespective of HF aetiology as a result of reduced LV 
basal and AR (Mor-Avi et al., 2011). In particular, the typical counterclockwise rotation of the LV 
apex may be completely abolished, or even reversed in a clockwise rigid body rotation [apical and 
BR in the same direction] (RBR). Additionally, in patients with dilated cardiomyopathy, LV AR 
was significantly related to LV diameters, volumes, and sphericity index (Popescu et al., 2009).  
RBR was observed in a high percentage of patients with dilated cardiomyopathy (52%) with more 
severe LV remodelling seen in these patients compared with those with normally directed AR 
(Popescu et al., 2009). However, studies reporting the effects of myocardial ischaemia on LV twist 
described a reduction in LV AR but not clockwise RBR (Garot et al., 2002, Takeuchi et al., 2007b, 
Bansal et al., 2008, Tibayan et al., 2004, Nagel et al., 2000, Nucifora et al., 2010).  
 
RBR in patients with dilated cardiomyopathy and severely dilated ventricles could be explained by 
increased LV sphericity leading to widening of the apex (Popescu et al., 2009). In patients with 
severe LV remodelling in term of size, shape and severe systolic dysfunction, LV twist is 
depressed, due to the loss of the oblique architecture of the ascending and descending apical loop 
fibres (Popescu et al., 2009) which become more transverse and closely resemble the horizontal 
fibre orientation of the basal loop (Popescu et al., 2009). Clockwise RBR, assessed by tagging 
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MRI, was also found  in 12/21 patients with dilated cardiomyopathy (Setser et al., 2007) and in 
11/37 patients with idiopathic dilated cardiomyopathy using 2D STE (Meluzin et al., 2009). These 
studies are in agreement with Van Dalen et al (van Dalen et al., 2010) who have demonstrated that 
an optimal myofibre helix angle exists and is related to a certain value of  LV sphericity index. A 
change in cardiac shape may indeed lead to a change in the arrangement of myocardial fibres and 
thereby a change in LV twist (van Dalen et al., 2010). 
 
Hypertension is intimately related to left ventricular dysfunction and congestive HF, with the 
incidence of HF reported between 1% and 2% per year in HTP after excluding prior ischemic heart 
disease as a risk factor for HF (Lloyd-Jones et al., 2002, Drazner, 2011). Therefore, early detection 
of LV systolic dysfunction in HTP is a crucial issue. LV twist is a fundamental component of LV 
wall motion in assessing ventricular function. LV twist may provide incremental information on 
LV systolic performance apart from EF. Various clinical conditions such as hypertrophy may affect 
LV twist and consequently LV function by altering the distribution of LV myocardial wall stress 
(Ahmed et al., 2012). LV twist could be considered as a compensatory mechanism to 
counterbalance contraction abnormalities in order to maintain LV output in HHD (Cho et al., 
2006).  
 
Furthermore, little work has been done to examine the contribution of regional tissue deformation 
to myocardial dysfunction and subsequent HF in patients with hypertension. Whereas the 
association between hypertension and the development of HF is well recognized, the exact 
mechanism by which this process occurs has been difficult to elucidate (Drazner, 2005). The 
assumption that pure diastolic dysfunction is responsible for HF with preserved systolic function 
has been challenged over recent years (Sanderson, 2003, Burkhoff et al., 2003) with emerging 
evidence suggesting that many of these patients actually have detectable abnormalities in 
myocardial systolic function, if sensitive enough measures are used (Yip et al., 2002, Poulsen et al., 
2003, Yu et al., 2002). Evaluation of LV twist using speckle tracking is a sensitive technique used 
to assess cardiac performance and may be a better index of systolic function than EF in HTP. In an 
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African population, we postulate that myocardial strain and LV twist abnormalities (contractility 
indices) may be a contributing factor to systolic dysfunction in HTP with HF (normal EF and low 
EF).   
 
1.3 BIOMARKERS IN HYPERTENSIVE HEART DISEASE AND MYOCARDIAL 
DEFORMATION 
 
HHD has been considered as one of the most common aetiological conditions predisposing to HF. 
Although, hypertension increases the risk for developing HF (Levy et al., 1996), LVH itself is an 
independent risk factor for HF (Levy et al., 1996, Kannel et al., 1987). Furthermore, in spite of 
progressive advances in antihypertensive strategies over the years, the incidence of HF in HTP with 
LVH remains high and comparable with that of major cardiovascular events, such as stroke (Tocci 
et al., 2008). LV dilation and LVH are markers of LV remodelling, a key precursor of HF 
(Aurigemma et al., 2001). HF is a progressive disorder initiated after a primary insult with loss of 
functioning myocytes, or loss of myocardial contractility with pump dysfunction (Mann et al., 2012 
) [Fig 1.3.1]. Patients with LV dysfunction may be asymptomatic as a result of compensatory 
mechanisms (remodelling) activated to maintain physiological LV function with preserved 
functional capacity of the patient (Mann et al., 2012). However, compensatory mechanisms 
(remodelling) result in adverse changes in myocardium (secondary damage) with a decline in LV 
function [Fig. 1.3.1].   
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Figure 1.3.1 Pathophysiology of heart failure in hypertension 
 
The process of LV remodelling has an important effect on the biology of the cardiac myocyte, on 
changes in the myocyte and nonmyocyte components of the myocardium, and on the geometry and 
architecture of the LV (Mann et al., 2012) [Fig. 1.3.2]. Alterations of the structure and composition 
of cardiomyocyte and noncardiomyocyte compartments of the myocardium appear to play a central 
role in the pathogenesis of HF (Mann et al., 2012) [Fig. 1.3.2]. Among these alterations, changes in 
the quantity and quality of the extracellular matrix (ECM), including the collagen network, have 
been characterized that induce remodelling of the myocardium and ultimately deteriorate left 
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ventricular function and facilitate the development of HF. It is not the quantity but rather the 
quality (structural remodeling) of myocardium that contributes to compromised function. 
Myocardial remodelling results from modifications that are not necessarily adaptive to the initial 
insult, but pathologic and potentially self-perpetuating in a progressive vicious cycle (Mann et al., 
2012).  
 
Alterations that occur in failing myocardium involve cardiac myocytes and composition of the 
extracellular matrix (Mann et al., 2012). Failing human cardiac myocytes undergo changes that 
lead to a progressive loss of contractile function including cell hypertrophy; abnormal myocardial 
energetics secondary to mitochondrial abnormalities and altered substrate metabolism; progressive 
loss of myofilaments in cardiac myocytes; alterations in cytoskeletal proteins with disarray of the 
cytoskeleton and alterations in excitation-contraction coupling (Mann et al., 2012) [Fig. 1.3.2]. The 
cardiac myocyte component of the myocardium undergoes progressive myocyte loss, through 
necrotic, apoptotic, or autophagic cell death pathways, which contribute to progressive cardiac 
dysfunction and LV remodelling (Mann et al., 2012) [Fig. 1.3.2] . 
 
 
 
- 18 - 
 
 
 
Figure 1.3.2 Cardiac Remodelling 
 
Changes within the ECM constitute the second important myocardial adaptation that occurs during 
cardiac remodelling (Mann et al., 2012). The ECM forms a continuum between different cell types 
within the myocardium and provides a structural supporting network to maintain myocardial 
geometry during the cardiac cycle (Li et al., 1998, Thomas et al., 1998, Timms et al., 2002, 
Laviades et al., 1998) . Disruption or discontinuities within the fibrillar ECM network will result in 
a loss of normal structural support and continuity, resulting in myocyte fascicles being subjected to 
abnormal stress-and strain patterns during the cardiac cycle, which, in turn, will result in changes in 
myocardial geometry and function (Li et al., 1998, Thomas et al., 1998, Timms et al., 2002, 
Laviades et al., 1998) . Although the fibrillar collagen matrix was initially considered to form a 
relatively static complex, it is now recognized that these structural proteins can undergo rapid 
turnover and is highly responsive to biological and mechanical stimuli (Li et al., 1998, Thomas et 
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al., 1998, Timms et al., 2002, Laviades et al., 1998). During cardiac remodelling, important 
changes in the ECM include changes in fibrillar collagen synthesis and degradation, changes in the 
degree of collagen cross-linking, as well as loss of collagen struts that connect the individual 
cardiac myocytes (Li et al., 1998, Thomas et al., 1998, Timms et al., 2002, Laviades et al., 1998).  
 
In pressure overload hypertrophy as seen in hypertension, the increase in systolic wall leads to the 
addition of sarcomeres in parallel, an increase in myocyte cross-sectional area and increased LV 
wall thickening without chamber enlargement (Mann et al., 2012). Pressure overload is 
characterized by a period of compensation in which left ventricular concentric hypertrophy 
normalizes systolic wall stress and contractile function is preserved. The transition to declining LV 
performance is characterized by the onset of chamber dilatation with the failure of further 
concentric hypertrophic growth to normalize load, and progressive contractile dysfunction 
(Drazner, 2011). A number of observations suggest that the transition to failure relates mainly to 
cardiomyocyte loss due to both apoptosis and necrosis, changes in the composition of motor unit 
and cytoskeleton of cardiomyocytes and alterations in the metabolism of the extracellular matrix 
(Díez et al., 2005). Changes in the biology of the failing myocyte, as well as in the failing 
myocardium, are largely responsible for the progressive LV dilation and LV dysfunction that occur 
during cardiac remodelling with increasing sphericity and LV dilatation (Mann et al., 2012)      
[Fig. 1.3.2].  
 
HHD is characterized by complex changes in myocardial structure (e.g. enhanced cardiomyocyte 
growth, excessive cardiomyocyte apoptosis, accumulation of interstitial and perivascular collagen 
fibres, disruption of endomysial and perimysial collagen network) that induce the remodelling of 
the myocardium, and ultimately, impair left ventricular function and facilitate the development of 
HF (Díez et al., 2005). Hypertensive myocardial remodelling is the consequence of a number of 
pathological processes mediated by mechanical, neurohormonal, and cytokine routes, occurring in 
the cardiomyocyte and the non-cardiomyocyte compartments of the myocardium (Swynghedauw, 
1999). LV remodelling is associated with derangements in the dynamic balance between the 
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accumulation and breakdown of cardiac ECM (Li et al., 1998, Thomas et al., 1998, Timms et al., 
2002, Laviades et al., 1998). Alterations to the properties of the cardiac ECM, which consists of 
predominantly fibrillar collagen (Caulfield and Borg, 1979), are central to this remodelling process 
(Graham and Trafford, 2007, Jalil et al., 1989) as the cardiac ECM serves to maintain correct 
myocyte geometry and cardiac extension properties, and provides tensile strength to the tissue.  
 
The scaffolding of cardiomyocytes is provided by a network of fibrillar collagen subdivided into 
three components (Li et al., 1998, Thomas et al., 1998, Timms et al., 2002, Laviades et al., 1998).   
The epimysium is located on the endocardial and epicardial surfaces of the myocardium, where it 
provides support for endothelial and mesothelial cells (Li et al., 1998, Thomas et al., 1998, Timms 
et al., 2002, Laviades et al., 1998). The perimysium surrounds muscle fibres, and perimysial strands 
connect groups of muscle fibres together sustaining the tension between different muscle 
bundles(Li et al., 1998, Thomas et al., 1998, Timms et al., 2002, Laviades et al., 1998). The 
endomysium arises from the perimysium and surrounds individual muscle fibres (Li et al., 1998, 
Thomas et al., 1998, Timms et al., 2002, Laviades et al., 1998). Struts of endomysium tether 
muscle fibres together and function as the sites for connections to cardiomyocyte cytoskeletal 
proteins (Li et al., 1998, Thomas et al., 1998, Timms et al., 2002, Laviades et al., 1998). The 
remodeling of collagen occurs mainly in the perimysial and endomysial components and leads to 
the thickening of the collagen fibrils and fibres, an increase in the density of the endomysial weaves 
around the cardiomyocytes, and an increase in newly formed collagen fibres (Li et al., 1998, 
Thomas et al., 1998, Timms et al., 2002, Laviades et al., 1998).   
 
Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes synthesized and secreted by 
fibroblasts, endothelial, and inflammatory cells (Nagase et al., 2006) that are involved in the 
protein degradation in the ECM and play an important role in remodelling (López et al., 2006). 
Tissue inhibitors of metalloproteinases (TIMPs) are low-molecular-weight molecules that bind to 
MMPs forming MMP–TIMP complexes that exhibit an inhibitory control on MMPs  (Nagase et al., 
2006). In fact, TIMPs bind noncovalently to MMPs in a 1: 1 stoichiometry, preventing access to the 
 
 
- 21 - 
 
substrate. In physiological conditions, collagen turnover is precisely regulated to maintain a finely 
balanced equilibrium between synthesis and degradation.  
 
The interaction between the enzyme matrix metalloproteinase1 (MMP1) that initiates the 
degradation of collagen fibres within the heart, and its inhibitor tissue inhibitor of 
metalloproteinases1 (TIMP1) is of critical relevance in the maintenance of the integrity of the 
collagen network. In pathologic conditions, such as hypertension, the excessive inhibition, as 
anticipated by a relative excess of TIMPs over MMPs, will reduce collagen degradation and 
facilitate the deposition of fibrotic tissue [Fig 1.3.3], whereas the insufficient inhibition, as 
anticipated by a relative abundance of MMPs over TIMPs, will increase collagen degradation and 
promote the disruption and loss of the physiological collagen scaffold [Fig. 1.3.3] (Briones et al., 
2010, Spinale, 2007). 
 
Figure 1.3.3 Abnormalities in collagen turnover in hypertension 
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The pathology of the end-stage failing human heart is characterized by myocyte loss, myocardial 
collagen accumulation and collagen fibril disruption, remodelling of the ECM, and disorganization 
of the cardiac myofibrils (Weber et al., 1993, Alla et al., 2006, Varo et al., 1999). Congestive HF 
has been associated with maladaptive ECM remodelling resulting from an imbalance in the 
synthesis and degradation of ECM components (Weber et al., 1993, Laviades et al., 1998). It has 
been proposed that this maladaptive remodelling contributes to the diminished systolic performance 
as well as the decreased compliance of the failing human heart (Brilla CG, 1994). The mechanisms 
responsible for the alterations in the ECM in the failing human heart remain undefined. Indeed, 
increased MMP activity has been observed in the failing human heart (Tyagi et al., 1996). An 
increase in the expression or activity of MMPs results in increased proteolytic activity in the 
extracellular spaces, leading to increased extracellular remodelling. Alternatively, decreased 
expression of TIMPs can elicit a similar tissue response. Increased activity of MMPs or decreased 
expression of TIMPs can result in enhanced proteolytic activity, fibrillar collagen degradation, 
progressive myocyte loss, and ventricular dilatation and sphericalization. 
 
The identification of biomarkers of potential usefulness for the clinical handling of cardiac diseases 
evolving to HF has been a prolific field recently with the investigation of novel circulating 
biochemical markers of myocardial remodelling in HHD accelerating at a remarkable pace. 
Biomarkers either determined in the circulation as biochemical markers or detected in the heart by 
imaging technologies, can be defined as alterations in the constituents of tissues or body fluids that 
can be applicable in at least five clinical areas: screening, diagnosis, prognostication, prediction of 
disease recurrence, and therapeutic monitoring. In order for a circulating molecule to be considered 
a biochemical marker of myocardial remodelling it must fulfil several criteria.  
 
First of all, there must be a relationship between its expression in the myocardium and its blood 
concentration (González et al., 2009); secondly, there has to be a positive gradient from its 
concentration in coronary sinus blood towards its concentration in peripheral vein blood, proving 
its predominant cardiac origin (González et al., 2009); thirdly, there must be an association between 
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its concentration in blood with the cardiac structural and/or functional parameters reflecting the 
hallmarks of the myocardial changes under study (González et al., 2009); finally, its levels should 
vary in parallel with the changes in the above parameters induced by pharmacological treatment. 
On the other hand, the method of determination must be easy (i.e. ELISA), reproducible and low 
cost, and the biochemical marker must have a good sensitivity and specificity to detect the 
pathology under study. 
 
During the initial phases of HHD, the predominant process is increased synthesis of cardiomyocyte 
and ECM proteins (López et al., 2006). Much less is known about the subsequent phases of HHD, 
especially the transition from the compensated state to clinically apparent heart failure. In HHD, an 
increase in interstitial collagen (accumulated perimysium) is associated with diastolic heart failure, 
whereas degradation of endomysial and perimysial components of the collagen scaffolding is 
accompanied by ventricular dilatation and systolic heart failure (López et al., 2006). However, in 
impaired systolic function, the collagen content of the heart is increased and is mainly scar-related 
collagen deposition and perivascular fibrosis (López et al., 2006). Recently, Diez and colleagues 
revealed that enhanced MMP-mediated collagen degradation contributed to the LV dilation and 
decline in ejection fraction in HHD with systolic dysfunction (López et al., 2006).  
 
The relationship between excessive myocardial MMP1 activity, increased mysial collagen 
degradation, and progression to systolic HF has been shown experimentally through the use of 
transgenic models and humans (Baicu et al.,2003, Kim et al., 2000). The volume of myocardial 
tissue occupied by perimysial and endomysial collagen was lower in HTP with low EF than in HTP 
with preserved EF (López et al., 2006). These findings suggest that excessive MMP1 dependent 
degradation of mysial collagen may be related to the compromise of systolic function in HTP. Loss 
of inhibitory control of TIMP on MMP correlates with progression of left ventricular remodelling 
via increased MMP activity, ECM proteolysis, and myocardial remodelling changes (López et al., 
2006). These data suggest that the transition from compensated LVH to heart failure is associated 
with degradation of ECM.  
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In patients with systolic heart failure, perivascular fibrosis and scarring occupied a greater portion 
of the myocardium, while the number of interstitial collagen fibres was reduced (López et al., 
2006).  Perivascular and scar-related fibrosis secondary to excessive collagen synthesis and 
exaggerated perimysial and endomysial collagen degradation may contribute critically to 
deterioration of systolic function in HTP (López et al., 2006). Depending on the temporal sequence 
of the disease process and on the localization, either diffuse or focal of the injury, this pattern may 
coexist at variable degrees within the same myocardium. MMP activation can contribute to the 
fibrotic process by participating in a vicious circle in which ECM degradation promotes ECM 
protein synthesis and fibrosis. This pathway is particularly detrimental because the nature and 
organization of the newly synthesized ECM differs from that of the native ECM. 
 
The expression of MMPs is regulated at the transcriptional level by a variety of inflammatory 
cytokines, hormones and growth factors. It is likely that up-regulation of MMP1 in low EF HTP is 
a dynamic process and is determined by the co-occurrence of a number of intracellular and 
extracellular signals (López et al., 2006). For instance, a number of humoral factors (i.e., 
inflammatory mediators, neurohormones, and bioactive peptides) may contribute to MMP1 up-
regulation in HTP with low EF (Siwik and Colucci, 2004). Although MMPs are proteolytic 
enzymes that degrade ECM proteins, they have other functions beyond this activity, affecting 
different regulatory pathways in the remodeling process. 
 
 Moreover, increased MMP expression and activation are associated with inflammation, oxidative 
stress, and the activation of the renin–angiotensin–aldosterone system (Brassard et al., 2005, 
Deschamps et al., 2005). In addition, experimental evidence has been provided showing that 
following chronic neurohormonal activation, increased synthesis and release of MMPs into the 
local ECM of the cardiomyocyte occurs (Coker et al., 1999), which in turn could contribute to 
endomysial and perimysial collagen degradation and disruption. MMPs have significant effects on 
important biologically active proteins and peptides, such as transforming growth factor-b, and other 
profibrotic proteins and pathways (Wang et al., 2010). Indeed, the disruption of the ECM in 
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hypertensive cardiac remodeling may involve both profibrotic and proteolytic pathways, providing 
a possible explanation for the variability of results regarding MMP modulation. In addition, 
mechanical signals linked to LV wall stress may result in the induction of myocardial MMP1 
(Spinale, 2002). It has been demonstrated that acute MMP activation and disruption of the fibrillar 
collagen network in the pressure overload  hypertrophied myocardium causes a decrease in systolic 
performance without changing cardiomyocyte contractility (Baicu et al., 2003).  
 
A higher concentration of MMP1 has been found in coronary sinus blood compared with 
antecubital vein blood in patients with hypertensive but not in normotensive subjects (López et al., 
2006). Moreover, a highly significant direct correlation has been found between MMP1 detected in 
coronary blood and peripheral blood in HTP (López et al., 2006). Of interest, in patients with 
hypertension and HF, MMP1 concentration measured in peripheral blood increases in parallel with 
the increase in myocardial MMP1 expression and is higher in patients with loss of myocardial 
collagen scaffold (López et al., 2006). Thus, in the setting of steady-state production by 
extracardiac sources, an excess of circulating MMP1 in patients with HHD can be considered of 
cardiac origin.  
 
The peripheral MMP1:TIMP1 ratio may be useful as an index of the MMP1/TIMP1 balance within 
the myocardium (López et al., 2006). Furthermore, the ratio MMP: TIMP is higher in HTP with 
low EF than in patients with preserved EF (López et al., 2006). The clinical relevance of the 
MMP1:TIMP1 ratio determined in peripheral vein blood is further supported by its associations 
with parameters assessing LV systolic dysfunction (depressed EF) and remodelling (increased 
LVEDD) (López et al., 2006).  
 
Therefore, the determination of MMP1 and TIMP1 in serum might be a useful biochemical marker 
of alterations in the perimysial and endomysial collagen network involved in systolic deterioration 
and geometric dilatation of the left ventricular chamber in HTP with HF (López et al., 2006) adding 
further diagnostic and prognostic information for the assessment of these patients. It is possible that 
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changes in the ECM reflected by the MMP1:TIMP1 ratio, account for the varying morphology, EF 
and LV twist in HTP who present with HF. Thus far, no study has assessed the relationship 
between LV twist and markers of collagen turnover in HTP with HF. In this context, the 
assessment of myocardial deformation of the left ventricle with the markers of collagen turnover 
may help to understand the progression towards hypertensive HF and may help clarify its clinical 
impact on the prognosis of HHD. 
 
Several published studies describe LV twist forces in normal adults (Villari et al., 1997, Park et al., 
2008, Takeuchi et al., 2007a, Wang et al., 2007, Rothfeld et al., 1998, Helle-Valle et al., 2005, 
Notomi et al., 2005). There appears to be an increase in left ventricular twist with advancing age 
(Notomi et al., 2005, Sun et al., 2012a, Reckefuss N, 2011, Helle-Valle et al., 2005, Rothfeld et al., 
1998, Park et al., 2008, Takeuchi et al., 2007a, Wang et al., 2007). Whether this relates solely to the 
aging process or is associated with concomitant physiological or comorbid conditions that occur 
with aging is unknown. Normal deformation values vary among publications and depend on the 
vendor used, suggesting that reference values have to be obtained for each method and software 
(Carasso et al., 2012, Cameli et al., 2011, Sun et al., 2004, Marwick et al., 2009, Manovel et al., 
2010, Mor-Avi et al., 2011). Furthermore, the interpretation of functional data across a spectrum of 
ages requires consideration of the ventricular loading conditions and vascular impedance. In 
subjects of African descent, no data exist on the analysis of these parameters in normal individuals. 
Therefore, it is pertinent to establish normative reference values in an African population. 
 
1.4 IMPLICATIONS 
 
Assessment of myocardial mechanics may be tailored according to the clinical goals. The detection 
of altered longitudinal mechanics alone may suffice if the overall goal of analysis is to detect the 
presence of early myocardial disease. Further characterization of radial strain, CS, and twist 
mechanics may provide assessment of the transmural disease burden and pathophysiologic insight 
into the mechanism of LV dysfunction (Cho et al., 2006). The screening for hypertension and 
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provision of appropriate anti-hypertensive therapy remain important public health measures both in 
South Africa and elsewhere. Although, LVH has been shown to be an important predictor of 
cardiac morbidity and mortality in patients with hypertension, identification of more sensitive pre-
clinical markers of LV dysfunction remains an important treatment goal in the arena of 
hypertension. Additional sensitive markers of LV remodelling may not only serve to further 
elucidate the mechanism of progression from hypertension to HF, but may also allow for more 
intensive and targeted therapy in at risk patients to curb the epidemic of HF.   
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2. OBJECTIVES 
 
1. To establish normative values for myocardial deformation (systolic longitudinal, 
circumferential and radial) and twist mechanics in healthy subjects. 
2. To determine the twist mechanics and patterns of rotation in HTP with systolic LV 
dysfunction without coronary artery disease. 
3. To determine the relationship of biomarkers of collagen turnover (MMP1, TIMP1, MMP1: 
TIMP1 ratio) with myocardial deformation and twist mechanics in HTP with HF with 
normal EF and low EF without coronary artery disease. 
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3.1.1 ABSTRACT  
 
Background: Speckle tracking has emerged as a quantitative technique for assessing left 
ventricular (LV) function. However, no normative data for LV twist using speckle tracking 
echocardiography (STE) are available in the black population. This study assessed myocardial 
mechanics by determining LV twist parameters in different age groups using STE, and evaluated 
the effect of aging on LV twist in this population. 
 
Methods: The study population consisted of 127 healthy volunteers divided into four age groups: 
20-29 (n=34); 30-39 (n=33); 40-49 (n=29); and 50-65 (n=31) years. Parasternal short-axis images 
of three consecutive end-expiratory cardiac cycles at LV basal, papillary muscle and apical levels 
and apical four-chamber images were obtained. Apical rotation (AR) and basal rotation (BR) LV 
peak systolic rotation during ejection and instantaneous LV peak systolic twist (net twist, defined 
as maximal value of instantaneous AR minus BR) were measured. 
 
Results: Mean strain values were -17.28 ± 3.30% for longitudinal, -17.40 ± 3.29% for 
circumferential and 57.49 ± 3.32% for radial strain. Mean rotational values were: AR (5.56° ± 
1.98), BR (-3.31° ± 0.92) and net twist (8.87° ± 2.21). AR, BR and net twist increased with age, 
whereas longitudinal, circumferential and RS decreased with age. Multivariate linear regression 
analysis showed age as the main predictor of net twist (R
2
=0.82, P<0.0001). 
 
Conclusions: These data establish values for strain and twist in a normal black adult population. 
Net twist increases with age whereas strain parameters decrease. Age is the strongest independent 
predictor of LV twist. 
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3.1.2 INTRODUCTION 
 
Left ventricular (LV) twist is defined as the wringing motion whereby the LV apex rotates in an 
opposite direction with respect to the LV base about the LV long axis (Takeuchi et al., 2009). LV 
twist has a vital role in ensuring that blood is ejected in an efficient manner during systole. Twist 
mechanics of the left ventricle obtained using STE offer new insights into the assessment of LV 
performance. Speckle tracking is a novel echocardiographic technique for the evaluation of LV 
twist that has been validated against MRI tagging (Goffinet et al., 2009) and has contributed to an 
explosion of research utilizing this technique in various cardiac abnormalities. Several pathological 
states have been identified in which abnormality of LV twist is a significant contributing factor to 
LV systolic dysfunction. 
 
In healthy humans, there is a continuum of expression of cardiac structural and functional 
alterations that occur with aging (Lakatta, 2003c, Lakatta, 2003a, Lakatta, 2003b). These age-
associated cardiac changes may have relevance to the increased incidence of LV hypertrophy, 
chronic HF and atrial fibrillation seen with increasing age (Lakatta, 2003c, Lakatta, 2003a, Lakatta, 
2003b). Several published studies describe LV twist forces in normal adults (Villari et al., 1997, 
Park et al., 2008, Takeuchi et al., 2007a, Wang et al., 2007, Rothfeld et al., 1998, Helle-Valle et al., 
2005, Notomi et al., 2005). There appears to be an increase in left ventricular twist with advancing 
age (Notomi et al., 2005, Sun et al., 2012a, Reckefuss N, 2011, Helle-Valle et al., 2005, Rothfeld et 
al., 1998, Park et al., 2008, Takeuchi et al., 2007a, Wang et al., 2007). Whether this relates solely to 
the aging process or is associated with concomitant physiological or comorbid conditions that occur 
with aging is unknown. The aim of this study was to establish normal values for left ventricular 
twist in black Africans and evaluate the effect of aging on left ventricular twist in this population. 
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3.1.3  METHODS 
 
This was a single centre, observational, cross-sectional, prospective study. The study population 
comprised randomly chosen volunteers recruited from Chris Hani Baragwanath Hospital staff and 
visitors and Soweto community members from January 2011 to May 2012. All subjects underwent 
clinical evaluation, which included history and physical examination. Only subjects who were 
asymptomatic and normotensive, had no evidence of cardiovascular or systemic diseases on history 
and physical examination, and had normal 12-lead electrocardiogram underwent echocardiography. 
All subjects who had entirely normal echocardiograms and adequate image quality for speckle-
tracking analysis were enrolled in the study after informed consent was obtained. A total of 150 
subjects were screened for inclusion. Twenty-three subjects were excluded as a result of inadequate 
image quality, which did not allow for complete segmental assessment of LV rotation at both the 
basal and apical left ventricle. The remaining 127 subjects made up the study group. The subjects 
were classified into four age groups: 20-29 (n=34), 30-39 (n=33), 40-49 (n=29) and 50-65 (n=31) 
years. This study was approved by the University of Witwatersrand Ethics Committee (clearance 
number: M110204) (see appendix a) and Institutional Review Board. 
 
BP measurements 
 
A Dinamap automated BP monitor (1846 SX; CritikonInc, Tampa, Fla) was used to measure BP 
readings. BP was recorded in the sitting position. Patients sat quietly for 10 min prior to readings 
being taken. The patient’s arm was supported at heart level during BP measurements. The 
pneumatic bag must be 20% wider than the diameter of the upper arm and fully deflated between 
measurements. BP readings were taken every 3 minutes for 30 minutes. The mean of these 10 
readings (SBP, DBP, MAP, and HR) were calculated and recorded. 
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Echocardiography 
 
Comprehensive transthoracic echocardiography was performed using a commercially available 
system (iE33 xMATRIX, Philips Healthcare, Andover, MA) equipped with an S5-1 transducer 
(frequency: 1.7 MHz transmitted, 3.4 MHz received) according to a standardized protocol. Images 
were acquired with the patient in the left lateral decubitus position during quiet respiration. All data 
were transferred to an Xcelera workstation (Philips Healthcare) and analyzed offline. All 
echocardiographic measurements were averaged from three heartbeats. Measurements relating to 
chamber size and function were performed in accordance with the American Society of 
Echocardiography (ASE) chamber quantification guidelines (Lang et al., 2005) and the ASE 2010 
guidelines on right heart assessment (Rudski et al., 2010). Severity of mitral  and tricuspid 
regurgitation  were analyzed in accordance with the ASE guidelines on native valvular 
regurgitation (Zoghbi et al., 2003). EF was calculated from LV volumes by the modified biplane 
Simpson rule in accordance with the guidelines (Lang et al., 2005).  
 
From the mitral-inflow pattern, peak early (E) and late (A) filling velocities, E/A ratio, and E-
velocity deceleration time were measured. Tissue Doppler was performed at end-expiration in the 
pulsed-wave Doppler mode at the level of the inferoseptal side of the mitral annulus from an apical 
four-chamber view. To acquire the highest wall tissue velocities, the angle between the Doppler 
beam and the longitudinal motion of the investigated structure was adjusted to a minimal level. The 
spectral pulsed-wave Doppler velocity range was adjusted to obtain an appropriate scale. The time 
intervals between the peak of the R wave on the electrocardiogram and the aortic valve opening 
and closure, and between the R wave and the mitral valve opening and closure were measured 
using pulsed Doppler acquired from the LV outflow and inflow, respectively.  
 
Left ventricular mass was calculated using the formula: LV mass = 0.8 × [1.04[(LVIDd + PWTd + 
SWTd)
3
 – (LVIDd)3]] + 0.6 g, where LVIDd, PWTd and SWTd are left ventricular internal 
diameter at end diastole, posterior wall thickness at end diastole and septal wall thickness at end 
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diastole, respectively (Lang et al., 2005, Ganau et al., 1992). Relative wall thickness was calculated 
using the formula: (2 × PWTd)/LVIDd (Lang et al., 2005, Ganau et al., 1992). The formula for 
body surface area:  BSA =[(0.0001x weight in kg)* 0.425] x[ height in cm)* 0.725] (Lang et al., 
2005). 
 
Speckle-Tracking Analysis 
 
Two-dimensional images were obtained at a frame rate of 60 to 80 frames/s. Parasternal short-axis 
images at the LV basal level showing the tips of the mitral valve leaflets were obtained with cross 
sections as circular as possible. To obtain a short-axis image at the true LV apical level, the 
transducer was positioned one or two intercostal spaces more caudally and acquired in a manner 
described by (van Dalen et al., 2008c). LV LS analysis was performed using an apical four-
chamber view. Foreshortened images were avoided by looking for the largest long-axis dimensions. 
From short-axis views, radial strain, CS and rotational data were averaged across six wall segments 
(anteroseptal, anterior, lateral, posterior, inferior and septal) at the basal and apical levels. Global 
CS was also measured from parasternal short-axis views at papillary muscle level. The width of the 
region of interest was adjusted to include the entire myocardium. Analysis of the datasets was 
performed using QLAB Advanced Quantification Software Version 8.0 (Philips, Best, 
Netherlands). In all instances the mean longitudinal, circumferential and RS for each subject was 
calculated by the sum of the strain measured in each anatomic region divided by the number of 
segments analyzed in that particular view. 
 
To assess LV rotation, six tracking points were placed on an end-diastolic frame (Van Dalen et al., 
2009) in each parasternal short-axis image automatically encompassing endocardium and 
epicardium. Tracking points were separated about 60 degrees from each other and placed at 1 
o’clock (30°, anteroseptal insertion into the LV via the right ventricle), 3 o’clock (90°), 5 o’clock 
(150°), 7 o’clock (210°), 9 o’clock (270°, inferoseptal insertion into the LV via the right ventricle) 
and 11 o’clock (330°) to fill the total LV circumference (Van Dalen et al., 2009). In all instances in 
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which tracking points were manually manipulated to optimize speckle tracking, no tracking points 
were allowed to be moved more than 30 degrees. Data were exported to a spreadsheet program 
(Excel, Microsoft Corp., Redmond, WA). Counterclockwise rotation as viewed from the apex was 
expressed as a positive value; clockwise rotation was expressed as a negative value. End systole 
was defined as the point of aortic valve closure. 
 
Analysis was performed to evaluate the peak basal and apical bulk rotations during the ejection 
phase and the net instantaneous twist of the LV, which was calculated as peak apical rotation (AR) 
minus basal rotation (BR) at a time isochronous with the peak AR. Analysis was performed to note 
the patterns of AR and BR during isovolumic contraction and during the ejection phase 
characterized by clockwise BR and counterclockwise AR in systole. The curves generated by the 
QLAB software include automated analysis of subendocardial and subepicardial regions by speckle 
tracking at the base and apex. In all subjects, the direction, timing and peak values of 
subendocardial and subepicardial rotations at both the apex and base were documented. The 
untwisting rate was defined as the mean diastolic untwisting velocity from instantaneous peak 
systolic twist to mitral valve opening and calculated as follows: (twist at mitral valve opening − 
peak systolic twist)/(time interval from peak systolic twist to mitral valve opening). 
 
Statistical Analysis 
 
Database management and statistical analyses were performed with SAS software (Version 9.2, 
SAS Institute Inc., Cary, NC). Data are presented as mean ± standard deviation. Continuous 
variables between age categories were compared using ANOVA, or Kruskal-Wallis test when the 
distribution was non-normal. Two-by-two comparisons were then performed applying Bonferroni 
correction with a p-value <0.0083 denoting significance. Univariate and multivariate linear 
regression analysis were used to identify possible independent determinants of net twist. Six 
separate models to predict net twist were used in a multiple linear regression analysis. The 
interobserver variability was assessed for twist measurements in 20 randomly selected patients and 
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calculated as the standard deviation of the differences between measurements of two independent 
observers who were unaware of the other patient data; these calculations were expressed as a 
percentage of the average value. The intraobserver variability was calculated as the standard 
deviation of the differences between a first and second determination of a single observer, and 
expressed as a percentage of the average value. P-values <0.05 were considered statistically 
significant.  
 
3.1.4  RESULTS 
 
Patient Selection 
 
A total of 150 normal subjects were screened for inclusion in the study. Inadequate visualization of 
the endocardial border precluded correct wall motion tracking in 23 individuals, who were 
eventually excluded from the analysis. The remaining 127 subjects showed adequate tracking for 
apical and basal short-axis views and were consecutively included. 
 
Baseline and Echocardiographic Characteristics 
 
The baseline general characteristics of the study sample are represented in Table 3.1.1. A 
significant increase in systolic BP (p=0.03), indexed LV mass (p=0.002) and relative wall thickness 
(p=0.008) was observed with increasing age. The indices of diastolic function showed that the peak 
E velocity decreased (p=0.06), while the A velocity increased (p=0.01), resulting in a progressive 
decrement in E/A ratio (p<0.0001) (Table 3.1.1). Peak E` medial wall velocity and peak E` lateral 
wall velocity decreased significantly with age (p=0.03 and p<0.0001, respectively) (Table 3.1.1). 
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TABLE 3.1.1   BASELINE CLINICAL AND ECHOCARDIOGRAPHIC CHARACTERISTICS 
Variable Total 20-29 30-39 40-49 50-65 P 
No. 127 34 33 29 31  
Age (years) 39.7 ± 12.1 25.0 ± 2.8 34.9 ± 2.2 45.0 ± 2.7 55.8 ± 4.9 <0.0001 
Sex (F:M ratio) 64:63 18:16 15:18 15:14 16:15 0.45 
BMI (kg/m
2
) 24.9 ± 2.4 24.2 ± 2.6 24.2 ± 3.0 25.5 ± 2.0 25.7 ± 1.3 0.06 
BSA (m
2
) 1.7 ± 0.2 1.8 ± 0.2 1.7 ± 0.2 1.8 ± 0.1 1.7 ± 0.1 0.10 
SBP (mmHg) 124 ± 5 123 ± 5 123 ± 6 125 ± 5 126 ± 4 0.03 
DBP (mmHg) 77 ± 9 74 ± 10 76 ± 9 80 ± 6 78 ± 8 0.05 
PP (mmHg) 47 ± 8 49 ± 9 47 ± 8 45 ± 6 47 ± 8 0.30 
Heart rate 
(bpm) 
73 ± 10 70 ± 10 75 ± 9 77 ± 9 71 ± 11 0.01 
EDD (mm) 45 ± 4 45 ± 4 45 ± 4 45 ± 3 46 ± 3 0.89 
IVSD (mm) 10 ± 2 9 ± 2 10 ± 2 10 ± 1 10 ± 2 0.007 
LVPWD (mm) 9 ± 1 8 ± 1 8 ± 1 9 ± 1 9 ± 1 0.009 
EDV (ml) 72.8 ± 9.7 73.4 ± 6.7 72.0 ± 9.7 73.9 ± 10.2 72.1 ± 11.8 0.75 
EDVI (ratio) 42.2 ± 6.1 42.0 ± 5.5 42.2 ± 5.9 41.9 ± 6.0 42.7 ± 7.4 0.77 
ESV (ml) 31.9 ± 8.2 32.5 ± 8.6 32.8 ± 7.9 32.8 ± 8.1 29.6 ± 8.4 0.30 
ESVI (ratio) 18.5 ± 4.7 18.4 ± 4.4 19.3 ± 5.1 18.6 ± 4.6 17.5 ± 4.8 0.55 
EF (%) 62.4 ± 7.0 61.8 ± 7.1 60.4 ± 6.9 62.3 ± 6.1 65.2 ± 7.4 0.06 
RWT (ratio) 0.38 ± 0.05 0.36 ± 0.05 0.37 ± 0.06 0.39 ± 0.04 0.40 ± 0.04 0.008 
LVMI (g/m
2
) 81.4 ± 18.0 72.5 ± 19.7 80.8 ± 17.2 83.9 ± 15.0 89.4 ± 15.5 0.002 
LAVI (ml/m
2
) 22.6 ± 3.2 22.6 ± 2.4 22.2 ± 4.7 22.4 ± 2.5 23.4 ± 2.5 0.34 
E (cm/s) 86.9 ± 14.5 88.8 ± 14.7 91.4 ± 17.2 84.4 ± 14.0 82.4 ± 9.8 0.06 
A (cm/s) 60.0 ± 11.0 54.6 ± 10.9 62.3 ± 11.1 60.5 ± 10.0 62.9 ± 10.3 0.01 
Decel time (ms) 171± 15 173 ± 13 167 ± 16 172 ± 14 171 ± 16 0.36 
E/A ratio 1.47 ± 0.22 1.66 ± 0.26 1.48 ± 0.19 1.40 ± 0.12 1.32 ± 0.12 <0.0001 
E` M (cm/s) 11.6 ± 1.2 12.0 ± 1.3 11.8 ± 1.2 11.6 ± 1.2 11.1 ± 0.7 0.03 
E` L (cm/s) 14.5 ± 2.1 15.6 ± 2.3 15.5 ± 1.8 13.8 ± 1.3 13.0 ± 1.3 <0.0001 
E/E` ratio 6.66 ± 0.92 6.47 ± 0.98 6.70 ± 1.06 6.63 ± 0.78 6.86 ± 0.79 0.40 
Data reported as mean ± standard deviation. 
BMI, body mass index; BSA, body surface area; DBP, systolic blood pressure; Decel time, Deceleration time; 
EDD, end-diastolic diameter; EDV, end-diastolic volume; EDVI, end-diastolic volume index; EF, ejection 
fraction; E` L, peak E` lateral wall velocity; E` M, peak E` medial wall velocity; ESV, end-systolic volume; 
ESVI, end-systolic volume index; F:M, female to male; IVSD, interventricular septum end-diastolic diameter; 
LAVI, left atrial volume index; LVMI, left ventricular mass index; LVPWD, left ventricular posterior wall 
diameter; PP, pulse pressure; RWT, relative wall thickness; SBP, systolic blood pressure. 
 
Left Ventricular Strain and Rotation Analysis 
 
Mean strain values for all subjects were -17.28 ± 3.30% for LS, -17.40 ± 3.29% for CS and 57.49 ± 
3.32% for RS (Table 3.1.2). All subjects had normal pattern of rotation with AR moving in a 
counterclockwise direction and BR recorded in a clockwise direction during systole. Mean 
rotational values for the study sample were 5.56 ± 1.98° for AR, -3.31 ± 0.92° for BR and 8.87 ± 
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2.21° for net LV twist (Table 3.1.3). Mean subendocardial and subepicardial rotational values for 
both AR (5.74 ± 2.04° vs. 5.44 ± 1.96°, respectively) and BR (-3.33 ± 0.96° vs. -3.10 ± 1.14°, 
respectively) were evaluated in all subjects (Table 3.1.3). Both subendocardial and subepicardial 
rotation values for the apex (counterclockwise, positive values) and base (clockwise, negative 
values) were recorded in the same direction (Figure 3.1.1) in all subjects. The mean untwisting rate 
was 52.19 ± 5.56 degrees/sec (Table 3.1.3). 
 
TABLE 3.1.2   STRAIN PARAMETERS WITH AGE 
Variable Total 20-29 30-39 40-49 50-65 P 
No. 127 34 33 29 31  
LS (%) -17.28 ± 3.30 -21.76 ± 0.84 -17.71 ± 0.76 -15.66 ± 0.76 -12.90 ± 1.17 <0.0001 
CS (%) -17.40 ± 3.29 -21.56 ± 0.96 -18.41 ± 0.29 -15.69 ± 0.74 -12.88 ± 1.17 <0.0001 
RS (%)  57.49 ± 3.32  61.71 ± 0.91  58.51 ± 0.52  55.71 ± 0.72  52.80 ± 1.28 <0.0001 
Data reported as mean ± standard deviation. 
CS, circumferential strain; LS, Longitudinal Strain; RS, Radial Strain. 
 
TABLE 3.1.3   ROTATIONAL PARAMETERS WITH AGE 
Variable Total 20-29 30-39 40-49 50-65 P 
No. 127 34 33 29 31  
AR (deg) 5.56 ± 1.98 4.11 ± 0.74 4.41 ± 0.88 5.73 ± 1.21 8.22 ± 1.56 <0.0001 
Subendo AR 
(deg) 
5.74 ± 2.04 4.30 ± 0.81 4.53 ± 0.94 5.92 ± 1.32 8.45 ± 1.62 <0.0001 
Subepi AR 
(deg) 
5.44 ± 1.96 4.00 ± 0.68 4.32 ± 0.81 5.58 ± 1.19 8.09 ± 1.62 <0.0001 
BR (deg) -3.31 ± 0.92 -2.64 ± 0.64 -3.37 ± 0.87 -3.52 ± 0.73 -3.77 ± 1.03 <0.0001 
Subendo BR 
(deg) 
-3.39 ± 0.94 -2.77 ± 0.67 -3.43 ± 0.94 -3.59 ± 0.70 -3.85 ± 1.07 <0.0001 
Subepi BR 
(deg) 
-3.16 ± 1.12 -2.34 ± 1.26 -3.29 ± 0.88 -3.41 ± 0.82 -3.68 ± 0.98 <0.0001 
Time to peak 
rotation (ms) 
357 ± 41 342 ± 38 353 ± 44 361 ± 28 372 ± 46 0.02 
Net twist 
(deg) 
8.87 ± 2.21 6.75 ± 0.81 7.79 ± 0.74 9.25 ± 0.90 12.00 ± 1.38 <0.0001 
Untwist rate 
(deg/sec) 
52.19 ± 5.56 55.40 ± 2.82 49.14 ± 6.38 50.22 ± 5.50 53.75 ± 4.61 <0.0001 
Data reported as mean ± standard deviation. 
AR, apical rotation; BR, basal rotation; Subendo AR, subendocardial apical rotation; Subepi AR, subepicardial 
apical rotation; Subendo BR, subendocardial basal rotation; Subepi BR, subepicardial basal rotation. 
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Figure 3.1.1    Subendocardial and subepicardial rotations at apex (Panel A) and base (Panel B). BA = 
basal anterior; BAL = basal anterolateral; BAS = basal anteroseptal; BI = basal inferior; BIL = basal 
inferolateral; BIS = basal inferoseptal. 
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Age-Related Changes in Strain and Left Ventricular Twist 
 
There was a significant decrease in longitudinal (p<0.0001), circumferential (p<0.0001) and RS 
(p<0.0001) with advancing age (Table 3.1.2). Net twist increased with advancing age (p<0.0001) 
and was accompanied by an increment in both AR (p<0.0001) and BR (p<0.0001) (Table 3.1.3, 
Figure 3.1.2). Differences in AR were progressively more pronounced after age 30 (4.41 ± 0.88° 
[30-39]; 5.73 ± 1.21° [40-49]; 8.22 ± 1.56° [50-65]; p<0.0001) (Table 3.1.3, Figure 3.1.2).There 
were no significant differences in BR among age groups ≥40 (p>0.05) (Figure 3.1.2). Net twist 
changed substantially in those ≥40 years old (9.25 ± 0.90° [40-49]; 12.00 ± 1.38° [50-65]) (Figure 
3.1.2). Subendocardial and subepicardial rotational values at the apex and base increased with age 
(p<0.0001) (Table 3.1.3). There was a significant increase in time to peak rotation during aging 
(p=0.02) (Table 3.1.3). 
 
 
Figure 3.1.2    Age-related values in peak rotation and twist parameters. *p<0.0001 when compared to 
the age 20-29 group. #p=0.0005 when compared to the age 30-39 group. AR = apical rotation; BR = 
basal rotation. 
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Factors Determining Left Ventricular Twist 
 
Univariate linear regression analysis showed that age, EF, left ventricular mass index (LVMI), E/A 
ratio, and longitudinal, circumferential and RS were independently associated with net twist 
(p<0.05 to p<0.0001) (Table 3.1.4). Table 3.1.5 summarizes the results of a multivariate linear 
regression analysis identifying predictors of net twist in different models. Insertion of EF, systolic 
BP, LVMI, end-systolic volume index, body surface area, pulse pressure, E/A ratio, peak E` lateral 
wall velocity, untwist rate, and longitudinal, radial and CS as potential covariates in six different 
models of multivariate analyses did not change the final models generated, which demonstrated age 
and male sex as the main independent predictors of net twist (Table 3.1.5). 
 
TABLE 3.1.4   UNIVARIATE LINEAR REGRESSION ANALYSIS FOR NET TWIST 
Variable β coefficients ± 
standard error 
R
2
 P 
Age 0.164  ± + 0.007 0.80 <0.0001 
Sex (F:M ratio) 0.476  ± + 0.392 0.01 0.23 
Body surface area (m
2
) -2.654  ± + 1.340 0.03 0.05 
Systolic blood pressure (mmHg) 0.066 ± 0.039 0.02 0.09 
Pulse pressure (mmHg) -0.019 ± 0.025 0.005 0.44 
Heart rate (bpm) 0.003 ± 0.020 0.0002 0.87 
LVMI (g/m
2
) 0.037 ± 0.010 0.09 0.0006 
Ejection fraction (%) 0.063 ± 0.028 0.04 0.02 
ESVI (ratio) -0.067 ± 0.042 0.02 0.11 
E/A (ratio) -4.765 ± 0.776 0.23 <0.0001 
Peak E` lateral wall velocity (cm/s) -0.004 ± 0.016 0.0005 0.80 
Untwist rate (deg/sec) 0.001 ± 0.036 0.0001 0.97 
Longitudinal strain (%) 0.577 ± 0.031 0.74 <0.0001 
Circumferential strain (%) 0.590 ± 0.029 0.77 <0.0001 
Radial strain (%) -0.524 ± 0.033 0.67 <0.0001 
ESVI, end-systolic volume index; LVMI, left ventricular mass index. 
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TABLE 3.1.5   MULTIVARIATE LINEAR REGRESSION ANALYSIS FOR NET TWIST 
Variable β coefficients ± standard 
error 
P 
Model 1   
Age (years) 0.167 ± 0.008 <0.0001 
Sex (F:M ratio) 0.382 ± 0.176 0.03 
Systolic blood pressure (mmHg) -0.015 ± 0.018 0.41 
Pulse pressure (mmHg) -0.004 ± 0.005 0.49 
Model 2   
Age (years) 0.167 ± 0.008 <0.0001 
Sex (F:M ratio) 0.382 ± 0.176 0.03 
Pulse pressure (mmHg) 0.004  ± 0.011 0.73 
LVMI (g/m
2
) -0.003 ± 0.005 0.57 
Model 3   
Age (years) 0.159 ± 0.007 <0.0001 
Sex (F:M ratio) 0.491 ± 0.177 0.006 
Body surface area (m
2
) -1.230 ± 0.617 0.05 
ESVI (ratio) -0.031 ± 0.021 0.14 
Ejection fraction (%) 0.011 ± 0.014 0.45 
Model 4   
Age (years) 0.162 ± 0.007 <0.0001 
Sex (F:M ratio) 0.412 ± 0.175 0.02 
ESVI (ratio) -0.027 ± 0.011 0.19 
Ejection fraction (%) 0.009 ± 0.014 0.53 
Model 5   
Age (years) 0.165 ± 0.009 <0.0001 
Sex (F:M ratio) 0.360 ± 0.180 0.04 
Untwist rate (deg/sec) 0.017 ± 0.016 0.30 
Peak E` lateral wall velocity (cm/s) 0.068 ± 0.492 0.89 
E/A (ratio) -0.005 ± 0.007 0.50 
Model 6   
Age (years) 0.133 ± 0.034 0.0002 
Sex (F:M ratio) 0.376 ± 0.177 0.04 
Longitudinal strain (%) -0.002 ± 0.108 0.99 
Circumferential strain (%) 0.127 ± 0.127 0.32 
Radial strain (%) 0.009 ± 0.072 0.90 
Multiple correlation coefficients are R
2
=0.81, p<0.0001 for Models 1, 2, 4, 5, and 6; 
and R
2
=0.82, p<0.0001 for Model 3. 
 
Reproducibility of results 
 
Intraobserver and interobserver variability for LV rotation parameters (AR, BR net twist, LS, CS, 
and radial strain) in our center varies from 2 ± 3% to 10 ± 9%, and from 4 ± 4% to 12 ± 8%, 
respectively. 
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3.1.5  DISCUSSION 
 
This study describes normative values for LV twist and its determinants in a black adult population. 
The pattern of rotation during systole in our study was that of the apex rotating counterclockwise 
while the base rotated in a clockwise direction. Regional subepicardial and subendocardial rotation 
at the apex and base were both counterclockwise and clockwise, respectively, in keeping with the 
overall global pattern of rotation observed at these anatomical sites. There was a trend of increasing 
AR, BR and net twist with aging, whereas longitudinal, radial and CS decreased with aging. Age 
and male gender were the main independent predictors of LV twist following multivariate 
regression analysis. 
 
Twist mechanics of the LV occur as a result of torsional deformation about the longitudinal axis 
and are initiated by the interaction between the systolic clockwise rotation of the base and the 
counterclockwise rotation of the apex (Sengupta et al., 2008b). Twist is the net difference between 
AR  and BR  when the LV is viewed from the apex (Sengupta et al., 2008b, van Dalen et al., 
2008b). Speckle tracking is a novel method for obtaining these parameters and can be performed in 
the clinical setting. In subjects of African descent, no data exist, to our knowledge, on the analysis 
of these parameters in normal individuals. Our findings reveal that the values of BR, AR and net 
twist using the QLAB software do not differ from findings in other populations using this vendor’s 
technology (van Dalen et al., 2008b). Additionally, the values obtained for AR and BR in this study 
are less than those reported in normal populations using different vendor technologies (van Dalen 
et al., 2008b, Zhang et al., 2007, Zhang et al., 2010, Takeuchi et al., 2006). 
 
To our knowledge, this study is the first to evaluate the rotation of the subepicardial and 
subendocardial regions at the base and apex using speckle tracking in a normal black population. 
Our findings reveal that, at the base and apex, the subendocardial and subepicardial rotations occur 
in the same direction as each other, peak simultaneously but differ in magnitude. These findings are 
in keeping with those of other studies (Bertini et al., 2010, Carasso et al., 2012, Nottin et al., 2008) 
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in which speckle tracking was performed to evaluate the subendocardial and subepicardial regions. 
In these studies, the direction of rotation of the subendocardium and subepicardium at basal and 
apical levels are the same as the direction of the global rotation at apical and basal levels (Nottin et 
al., 2008, Bertini et al., 2010, Carasso et al., 2012). These patterns of rotation are noted irrespective 
of the speckle-tracking vendor technology used (Carasso et al., 2012, Bertini et al., 2010, Nottin et 
al., 2008). 
 
It is postulated that subendocardial fibres in the apex and base move in the same direction, whereas 
the subepicardial fibres in these regions move in an opposite direction and that the interaction 
between these fibres in the helical architecture contributes to LV twist (van Dalen et al., 2008b). 
Net rotation is thought to be predominantly counterclockwise at the apex due to the longer arm of 
rotation of the subepicardial fibres. This postulate cannot be assessed in this study since the 
technique of speckle tracking only tracks the movement of speckles in these anatomical regions. 
This is not synonymous with an assessment of myocardial fibre movement in these regions. We 
postulate that perhaps current speckle-tracking technology is unable to sufficiently assess fibre 
movement due to its limitations with regard to both spatial and temporal resolution. A further 
limitation is that the technology utilized in this study is only a two-dimensional assessment of 
speckle movement in these regions, which may be more accurately assessed by three-dimensional 
speckle tracking. Thus, the assessment of myocardial fibre arrangement in these regions and the 
actual rotatory forces exerted by these fibres in humans cannot be detected by current speckle-
tracking technology. 
 
Aging affects many aspects of cardiovascular function (Lakatta, 2003c, Lakatta, 2003a, Lakatta, 
2003b, Lakatta and Sollott, 2002, Oxenham et al., 2003). Advancing age is associated with 
structural and functional changes in the myocardium, e.g. myocardial fibrosis and impaired 
coronary perfusion (Oxenham et al., 2003, Lakatta, 2003c, Lakatta, 2003a, Lakatta, 2003b). 
Increased LV wall thickness, alterations in the diastolic filling pattern, impaired LV ejection and 
heart rate reserve capacity are the most dramatic changes in cardiac function that occur with aging 
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in healthy persons (Lakatta, 2003c, Lakatta, 2003a, Lakatta, 2003b). Although these age-associated 
changes do not always reflect clinical heart disease per se, they may compromise cardiac reserve 
and alter the threshold for disease manifestation. 
 
To our knowledge this is the first study to evaluate all aspects of twist and strain with aging using 
STE in a black population. Our findings reveal that net twist increased with age due to an increase 
in both BR and AR. However, there appears to be a temporal dispersion in the increment of apical 
and BR. We observed that AR increased substantially after age 40 whereas no significant increment 
occurred in BR after age 40. The result is that the major increment in net twist observed occurred 
after age 40. In accordance with our study, BR also was less influenced by age in other published 
data (van Dalen et al., 2008b, Zhang et al., 2007, Takeuchi et al., 2006, Zhang et al., 2010). Van 
Dalen et al. reported a mean value of peak LV twist as 7.7 ± 3.58° in a white population (van Dalen 
et al., 2008b), with peak LV twist significantly greater in subjects aged ≥60 years (10.8 ± 4.98°) 
compared with those aged ≤40 years (6.7 ± 2.98°) and those aged 41 to 59 years (8.0 ± 3.08°) (van 
Dalen et al., 2008b). Takeuchi et al. examined the effect of aging on twist in 113 Asian volunteers; 
peak LV twist increased significantly in those aged ≥60 years with similar values as published on 
whites (Takeuchi et al., 2006). Furthermore, (Zhang et al., 2010) showed a greater increment in AR 
from subjects aged 45 to 55 years (7.94 ± 1.20°) to those aged 55 to 65 years (9.65 ± 1.56°), and a 
lesser increase in BR [-6.50 ± 2.49° (45-55 years) vs. -7.07 ± 1.25° (55-65 years)]. 
 
The characteristics of LV twist undergo substantial changes during the aging process. The increase 
in LV twist can be partially explained by lessened opposition to AR, which results from a gradual 
decrease in subendocardial function with aging (Zhang et al., 2010, van Dalen et al., 2008b, 
Takeuchi et al., 2006, Zhang et al., 2007). Impairment of subendocardial contractile function may 
be on the basis of ischemia or fibrosis and results in diminished clockwise systolic BR, which leads 
to less opposition of counterclockwise systolic AR, causing net twist to increase (Zhang et al., 
2007, Zhang et al., 2010, van Dalen et al., 2008b, Takeuchi et al., 2006).
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An analysis of other aspects of myocardial mechanics revealed a concurrent reduction in 
longitudinal, circumferential and RS with increasing age. Whereas some researchers described 
reduced strain with increasing age (tissue Doppler imaging (Dalen et al., 2010, Kuznetsova et al., 
2008) and
 
MRI (Fonseca et al., 2003)) or increasing strain with aging (STE) (Reckefuss N, 2011), 
others found no correlation between strain and age (tissue Doppler imaging) (Sun et al., 2004) in 
other populations. Moreover, some studies using speckle tracking found some strain parameters 
(circumferential and radial strain) increased (Sun et al., 2012a, Reckefuss N, 2011) while LS 
decreased (Sun et al., 2012a). Another possible rationale for the increase in twist with aging could 
be as a compensatory mechanism for decline in other strain parameters (Carasso et al., 2012). This 
may explain our observation that the time to peak twist increases with increasing age, which may 
occur as a result of greater compensatory rotation to counteract the concomitant declining function 
in other strain parameters. 
 
LV twist is an effective method to preserve LV systolic function, as the helical fibre architecture of 
the heart doubles the LV EF (Bertini et al., 2010, Nottin et al., 2008). We postulate that increased 
net twist with advancing age may demonstrate a possible contribution of net twist to preserving EF 
and maintaining normal systolic function of the left ventricle as found in other studies (Nottin et al., 
2008, Bertini et al., 2010). AR is the major contributing factor of LV twist, with an increase in AR 
resulting in an increase in twist. This implies that apical function is perhaps the most important 
determinant for LV twist, and one would expect that pathological states that impair apical function 
to a greater degree than other anatomic sites may result in greater LV dysfunction. However, age 
was the main independent predictor of net LV twist in our study. Furthermore, despite an increase 
in relative wall thickness, LVMI, systolic BP and changes in diastolic indices with advancing age 
in our study, conventional echocardiographic and clinical variables were not able to predict net LV 
twist. Cameli et al. showed an independent correlation of indexed end-systolic LV volume, LV 
relaxation, heart rate, gender and age with LV twist mechanics in normal individuals (Cameli et al., 
2011). However, echocardiographic and clinical variables were not independent predictors of LV 
twist mechanics (Cameli et al., 2011). Moreover, strain parameters showed an independent 
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correlation (longitudinal, circumferential and radial strain) with net LV twist in our study but were 
unable to predict net LV twist. 
 
Limitations 
 
The technique of speckle tracking used in this study only provides a two-dimensional analysis, and 
the consistency of these findings using other two-dimensional vendor technology is uncertain. MRI 
tagging or sonomicrometry were not employed as the gold standard to compare speckle-tracking 
findings. Normal deformation values vary among publications and depend on the vendor used, 
suggesting that reference values have to be obtained for each method and software (Carasso et al., 
2012, Cameli et al., 2011, Sun et al., 2004, Marwick et al., 2009, Manovel et al., 2010, Mor-Avi et 
al., 2011). The interpretation of functional data across a spectrum of ages requires consideration of 
the ventricular loading conditions and vascular impedance. Further research is required to assess 
the fibre structure and loading conditions that change with aging between different populations, as 
the response of the left ventricle in black patients in pathological states does differ (Marwick, 2010, 
Leitman et al., 2004, Kizer et al., 2004, Nunez et al., 2005). Further research is required to 
determine the effect of aging on strain and rotation using three-dimensional speckle tracking, 
preferably in an international multicenter cohort. 
 
3.1.6  CONCLUSION 
 
The data reported in this study establish the normal values and patterns for left ventricular strain 
and rotational mechanics in a normal black-African adult population and can be used as a baseline 
for future studies. Aging is associated with increased net LV twist whilst decreasing strain 
parameters are associated with advancing age. Age is the major determinant of increased LV twist 
in this population. 
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3.2.1  ABSTRACT 
 
Aims: Speckle tracking echocardiography (STE) has emerged as a quantitative technique to assess 
left ventricular (LV) function via twist mechanics. Hypertension-associated changes in LV twist 
have not been previously evaluated in African patients with LV systolic dysfunction. This study 
evaluates LV twist dynamics in HTP with low EF. 
 
Methods and Results: Forty-one HTP with EF <45% and normal coronary angiography (HTLEF  
Group) were compared with 41 control subjects using STE. Peak apical rotation (AR) and  
isochronous BR (BR) were measured, as was net twist (maximal value of simultaneous AR – BR).  
Rigid body rotation (RBR) was defined as AR and BR occurring in the same direction. Of 41  
HTLEF patients, 28 (68%) had normal twist pattern while 13 (32%) exhibited RBR; 11 of those 13  
exhibited clockwise rotation. AR (1.89°±0.99 vs. 7.15°±2.26; p<0.0001), BR (1.44°±0.78 vs. – 
3.75°±1.61; p<0.0001) and net twist (3.3°±1.17 vs. 10.9°±2.7; p<0.0001) were lower in HTLEF  
patients. The subgroup with clockwise RBR showed greater LV dysfunction (EF: 27.9±5.8% vs.  
35±7.5%; p=0.005) and more spherical LV geometry in both diastole and systole (p=0.0009 and  
p=0.0002, respectively) compared with those who had normal pattern of twist. In the HTLEF  
subgroup with normal twist pattern, AR (r=0.57; p=0.002) and net twist (r=0.57; p=0.002)  
correlated with EF. 
 
Conclusions: Left ventricular twist in patients with hypertension and EF less than 45% is  
diminished. AR and net twist are good correlates for EF in HTP with EF <45%. 
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3.2.2  INTRODUCTION 
 
Hypertension is a well-documented precedent to left ventricular (LV) dysfunction and congestive 
HF. In the Framingham Heart Study, lifetime risk for congestive HF was 20% for both men and 
women (Lloyd-Jones et al., 2002). Even after exclusion of patients with antecedent myocardial 
infarction, risk for HF remains significant (Drazner, 2011). Although the contribution of 
hypertension to HF is known, the mechanism is multifactorial and unclear (Drazner, 2011). It is 
generally postulated that the development of systolic dysfunction in HTP is either due to a 
myocardial infarction or as a consequence of concomitant ischemic heart disease (Drazner, 2011). 
Hypertension may cause systolic dysfunction as a consequence of adverse remodelling, but this has 
not been clearly documented (Drazner, 2011).
 
LV twist may be a contributing factor to this 
dysfunction independent of ischemic heart disease, thus, a focus on abnormalities in the cardiac 
mechanics of twist in the left ventricle may be helpful in understanding the pathogenesis behind the 
transition from compensated to decompensated HF. 
 
LV twist occurs when the LV apex moves in a counterclockwise direction during systole while the 
base moves in a clockwise direction. LV twist can now be accurately assessed using STE, which 
has been validated against MRI (Helle-Valle et al., 2005, Notomi et al., 2005). Evaluation of LV 
twist has proven a sensitive technique to assess cardiac performance (Taber et al., 1996, 
Greenbaum et al., 1981, Bell et al., 2000). We hypothesized that LV rotational parameters and net 
LV twist are diminished in hypertensive black patients with low EF in the absence of ischemic 
heart disease. In a population with no concomitant coronary disease, we compared LV twist and its 
components in HTP who presented with HF and low EF to healthy, normal subjects. 
 
3.2.3  METHODS 
 
This single centre, cross-sectional study was approved by the University of Witwatersrand Ethics 
Committee (clearance number: M110204) (see appendix a) and the Institutional Review Board. 
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Subjects were consecutively recruited from the Chris Hani Baragwanath Hospital Cardiac Clinic 
from January 2011 to October 2011. Inclusion criteria were: documented prior diagnosis of 
hypertension (measurements on three separate occasions where the systolic BP was ≥140 mmHg, 
or the diastolic BP was ≥90 mmHg taken over a period of two months (Seedat and Rayner, 2012)) 
at the Hypertension Clinic, documented HF (past or on presentation as evidenced by symptoms 
[New York Heart Association functional class], clinical examination and/or admissions for HF), 
sinus rhythm, EF <45% on echocardiography, and normal coronary angiography. 
 
Exclusion criteria were: previous myocardial infarction, anaemia (haemoglobin <12 g/dL in 
females, <13 g/dL in males), excess alcohol intake (maximum alcohol intake no more than 40 
grams per day in males and 20 grams per day in females with two alcohol-free days per week), 
renal dysfunction (glomerular filtration rate <60 mL/min/1.73 m
2
), documented diagnosis of 
diabetes and/or glycated haemoglobin >7%, organic valvular disease, dilated cardiomyopathy of 
any aetiology, cardiac infiltrative diseases, post-viral myocarditis, any systemic illness (e.g. human 
immunodeficiency virus [HIV]), thyroid disease, and any primary organ dysfunction or failure (e.g. 
chronic renal disease). Subjects who fulfilled the criteria and provided voluntary informed consent 
were enrolled and underwent a detailed clinical and echocardiographic evaluation at baseline. A 
total of 50 patients were screened for inclusion in the study. Nine patients were excluded as a result 
of inadequate image quality that did not allow for complete segmental assessment of LV rotation at 
both the basal and apical left ventricle. The remaining 41 HTP with low ejection fraction (HTLEF) 
made up the study group. 
 
The control group was recruited from the staff at Chris Hani Baragwanath Hospital, patient escorts 
and community members from Soweto. All members of the control group were unrelated to the 
patients in the HTLEF group. Individuals younger than 50 years were matched with a tolerance of 5 
years in terms of age, while individuals older than 50 years were allowed a tolerance of up to 10 
years. All members of the control group were asymptomatic, normotensive, had no evidence of 
cardiovascular or systemic diseases and had a normal 12-lead electrocardiogram prior to 
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undergoing echocardiography for the study. The control group was age- and sex-matched with the 
HTLEF cohort. Echocardiographic evaluation of the control group is part of an ongoing 
prospective study to provide normal reference ranges for echocardiographic measurements in 
subjects of African ancestry. 
 
BP measurements 
 
Please refer to 3.1.3. 
 
Echocardiography 
 
Please refer to 3.1.3.  Concentric hypertrophy was defined as RWT >0.42 and left ventricular mass 
index (LVMI) (g/m
2
) >95 in females and >115 in males, while eccentric hypertrophy was defined 
as RWT <0.42 and LVMI >95 in females and >115 in males (Lang et al., 2005, Ganau et al., 1992). 
LV sphericity index was calculated by dividing the LV maximal long-axis internal dimension by 
the maximal short-axis internal dimension at end diastole and end systole (van Dalen et al., 2010) 
using apical four-chamber view. 
 
Speckle-tracking analysis 
 
Two-dimensional images were obtained at a rate of 50 to 80 frames per second. Parasternal short-
axis images at the LV basal level showing the tips of the mitral valve leaflets were obtained with 
the cross-section as circular as possible. To obtain a short-axis image at the true LV apical level, 
the transducer was positioned one or two intercostal spaces more caudal and acquired in a manner 
described by van Dalen et al (van Dalen et al., 2008c). Analysis of datasets was performed using 
QLAB advanced quantification Version 8.0 software (Philips Healthcare, Best, Netherlands) by a 
physician experienced in speckle tracking. The assessment of LV twist using QLAB software had 
previously been validated against MRI tagging (Goffinet et al., 2009). 
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To assess LV rotation, six tracking points were placed on the myocardium (Van Dalen et al., 2009), 
avoiding the pericardium on an end-diastolic frame in each parasternal short-axis image as 
determined automatically by the nature of the software algorithm. At the base, tracking points were 
separated about 60 degrees from one another to fit the total LV circumference as described by Van 
Dalen et al (Van Dalen et al., 2009). Repositioning of tracking points was allowed provided the 
position was moved no more than 30 degrees. At the apex, tracking points were placed per the 
software algorithm from the endocardium to epicardium. After positioning the tracking points, the 
program tracked these points. The operator ensured that cardiac cycles with heart rate variability 
<10% were selected for the measurements of LV rotation parameters. Manual correction for region 
of interest repositioning was required in 6 (14.6%) control subjects and 10 (20%) HTP screened for 
inclusion in the study. Time needed for analysis was, on average, 2-3 minutes per patient. 
 
Counterclockwise rotation, as viewed from the apex, was expressed as a positive value; clockwise 
rotation was expressed as a negative value (Van Dalen et al., 2009). End systole was defined as the 
point of aortic valve closure. Analysis was performed to evaluate the peak apical rotation (AR) 
during the ejection phase, the basal rotation (BR) at a time isochronous with that of peak AR during 
the ejection phase and the net instantaneous twist of the left ventricle (net twist), which was 
calculated as peak AR minus the BR at a time isochronous with peak AR. 
 
In addition to quantifying AR and BR, we analyzed the direction of rotation in systole. We focused 
on the pattern of rotation during the ejection phase of systole and identified rotation as either 
normal or having evidence of RBR, which was either counterclockwise or clockwise at both the 
basal and apical levels. Normal patterns evaluated were characterized by clockwise systolic BR and 
counterclockwise systolic AR (van Dalen et al., 2011). The untwisting rate was defined as the mean 
diastolic untwisting velocity from instantaneous peak systolic twist to mitral valve opening and 
calculated thusly: (twist at mitral valve opening − peak systolic twist)/(time interval from peak 
systolic twist to mitral valve opening). 
 
 
 
- 54 - 
 
Statistical analysis 
 
Database management and statistical analyses were performed with SAS Version 9.2 software 
(SAS Institute Inc., Cary, NC). Data were presented as mean ± standard deviation. Continuous 
variables were compared using independent t-test or Wilcoxon-Mann-Whitney test when the 
distribution was non-normal. Spearman correlation coefficients for the relationships between LV 
rotation parameters against conventional echocardiographic parameters were determined. The 
interobserver variability was assessed for twist measurements in 20 randomly selected patients, 
calculated as the standard deviation of the differences between the measurements of two 
independent observers who were unaware of the other patient data, and expressed as a percentage 
of the average value. The intraobserver variability was calculated as the standard deviation of the 
differences between a first and second determination of a single observer and expressed as a 
percentage of the average value. Intraobserver and interobserver variability for LV rotation 
parameters in our centre varies from 2% ± 3% to 10% ± 9%, and from 4% ± 4% to 12% ± 8%, 
respectively. P-values less than 0.05 were considered statistically significant. 
 
3.2.4  RESULTS 
 
Patient selection 
 
A total of 50 patients with HTLEF were screened for inclusion in the study. Inadequate 
visualization of the endocardial border precluded correct wall-motion tracking in 9 patients, who 
were then excluded from the analysis. The remaining 41 patients showed adequate tracking for 
apical and basal short-axis views and were consecutively included (Table 3.2.1). The control group 
was comprised of 41 individuals. All patients from the HTLEF group were on optimal doses of beta 
blocker (carvedilol) and the angiotensin-converting enzyme inhibitors, spironolactone and 
furosemide. 
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Baseline and echocardiographic characteristics 
 
Baseline characteristics of the study population are represented in Table 3.2.1. Patients with 
HTLEF differed significantly from the patients in the control group with respect to age, body mass 
index and baseline BP. Adjustments were made in the data analysis to accommodate for these 
differences. As expected, patients with HTLEF differed significantly from the control group with 
regard to all echocardiographic measurements (Table 3.2.1). Two major geometric patterns were 
noted in subjects with HTLEF: concentric hypertrophy in 22 patients (54%) and eccentric 
hypertrophy in 19 patients (46%). 
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TABLE 3.2.1     BASELINE CLINICAL AND ECHOCARDIOGRAPHIC CHARACTERISTICS 
 Control group HTLEF group 
No. patients 41 41 
Age, years 50.1 ± 9.3 55.0 ± 9.1
#
 
Male gender, no. (%) 19 (46.3) 19 (46.3) 
Body mass index, kg/m
2
 24.7 ± 1.8 29.5 ± 5.0* 
Body surface area, m
2
 1.72 ± 0.14 1.86 ± 0.17* 
NYHA functional capacity, no. (%) 
Class I 
Class II 
Class III 
 
41 (100) 
 
12 (29)* 
14 (34)* 
15 (37)* 
Duration of hypertension, years --- 12.2 ± 6.5 
Duration of heart failure, years --- 3.2 ± 1.6 
Medication (ACE/ARB, diuretics,  
beta blocker, spironolactone) 
--- 41 
Systolic blood pressure, mmHg 120 ± 7 156 ± 8* 
Diastolic blood pressure, mmHg 71 ± 6 89 ± 10* 
Heart rate, bpm 73 ± 10 81 ± 10* 
EDD, mm 43 ± 5 58 ± 5
†
 
IVSD, mm 10 ± 1 12 ± 2
†
 
IVPWD, mm 8 ± 1 12 ± 2
†
 
End-diastolic volume, ml 80.6 ± 13.8 133.2 ± 41.2
†
 
End-diastolic volume index, ml/m
2
 46.8 ± 7.7 72.3 ± 23.6
†
 
End-systolic volume, ml 32.6 ± 9.8 91.1 ± 38.7
†
 
End-systolic volume index, ml/m
2
 18.9 ± 5.6 49.4 ± 21.4
†
 
Ejection fraction, % 69.3 ± 9.5 33.0 ± 7.6
†
 
Relative wall thickness ratio 0.38 ± 0.03 0.41 ± 0.06
#
 
Left ventricular mass index, g/m
2
 73.8 ± 13.9 161.4 ± 32.8
†
 
Left atrial volume index, ml/m
2
 23.0 ± 2.2 31.0 ± 16.3
#
 
Functional mitral regurgitation --- 1.83 ± 0.8 
End-diastolic LVSPHI ratio 1.88 ± 0.30 1.36 ± 0.12
†
 
End-systolic LVSPHI ratio 2.13 ± 0.54 1.39 ± 0.10
†
 
Peak E velocity (cm/s) 80.2+7.8 65.1+8.2
†
 
Peak A velocity (cm/s) 49.5 ± 8.4 85.3 ± 7.6
†
 
Deceleration time (ms) 170 ± 31 245 ± 44
†
 
E/A ratio 1.70 ± 0.34 0.77 ± 0.11
†
 
#
p<0.05. 
*p<0.0005. 
†
p<0.0001. 
A = late (atrial) ventricular filling velocity; ACE/ARB = angiotensin-converting enzyme 
inhibitors/angiotensin receptor blockers; E = early ventricular fillingvelocity; EDD = end-
diastolic diameter; HTLEF = patient study group with hypertension and low ejection fraction 
(<45%); IVPWD = interventricular posterior wall at end-diastolic dimension;  
IVSD = interventricular septal thickness at end-diastolic dimension; LVSPHI = left ventricular 
sphericity index; NYHA = New York Heart Association. 
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Left ventricular rotation analysis 
 
All subjects in the control group had normal pattern of rotation (Fig. 3.2.1). Three distinct 
rotational patterns were identified in the HTLEF group. Of the 41 patients with HTLEF, 28 patients 
(68%) had normal pattern of twist (Fig. 3.2.2, Table 3.2.2) while 13 (32%) exhibited RBR. Eleven 
of the 13 patients had evidence of clockwise RBR (Fig. 3.2.3 and Table 3.2.2) and two had 
counterclockwise RBR. AR (1.89° ± 0.99 vs. 7.15° ± 2.26; p<0.0001), BR (1.44° ± 0.78 vs. -3.75° 
± 1.61; p<0.0001) and net twist (3.3° ± 1.2 vs. 10.9° ± 2.7; p<0.0001) were lower in HTLEF 
patients compared to controls (Table 3.2.3). The untwisting rate was reduced in HTLEF patients 
compared to controls (p= 0.03) (Table 3.2.3). 
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Figure 3.2.1     (A) Normal apical rotation in control patients. Tracking points at the left ventricular 
apical level. Left ventricular rotation–time curve (x-axis: time in ms; y-axis: left ventricular apical 
rotation in degrees). Electrocardiogram is displayed at the bottom. (B) Normal basal rotation in 
control patients. Tracking points at the left ventricular basal level. Left ventricular rotation–time 
curve (x-axis: time in ms; y-axis: left ventricular basal rotation in degrees). Electrocardiogram is 
displayed at the bottom (arrow indicates peak global basal rotation at time of aortic valve closure). 
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Figure 3.2.2    (A) Apical rotation with normal pattern in hypertensive patients with ejection fraction <45%. 
Tracking points at the left ventricular apical level. Left ventricular rotation–time curve (x-axis: time in ms; y-axis: 
left ventricular apical rotation in degrees). Electrocardiogram is displayed at the bottom (arrow indicates peak 
global apical rotation at time of aortic valve closure). (B) Basal rotation with normal pattern in hypertensive 
patients with ejection fraction <45%. Tracking points at the left ventricular basal level. Left ventricular rotation–
time curve (x-axis: time in ms; y-axis: left ventricular basal rotation in degrees). Electrocardiogram is displayed at 
the bottom (arrow indicates peak global basal rotation at time of aortic valve closure). 
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TABLE 3.2.2     COMPARISON BETWEEN HTLEF PATIENTS WITH DIFFERENT PATTERNS OF TWIST 
 Normal pattern 
(n=28) 
Clockwise RBR 
(n=11) 
P-value 
Age, years 55.0 ± 9.7 56.0 ± 8.2 0.61 
Male gender, no. (%) 16 (57.1) 2 (18.1) 0.07 
Body mass index, kg/m
2
 28.8 ± 5.2 31.4 ± 4.6 0.17 
Body surface area, m
2
 1.86 ± 0.17 1.88 ± 0.18 0.99 
Systolic blood pressure, mmHg 156 ± 8 154 ± 9 0.49 
Diastolic blood pressure, mmHg 89 ± 10 93 ± 11 0.35 
Heart rate, bpm 78 ± 10 87 ± 8 0.02 
NYHA functional capacity, no. (%) 
Class I 
 
12 (43) 
 
0 (0) 
 
 
0.017 Class II 8 (28.5) 4 (36) 
Class III 8 (28.5) 7 (64) 
Duration of hypertension, years 11.3 ± 6.9 13.5 ± 4.2 0.06 
Duration of heart failure, years 3.1 ± 1.6 3.2 ± 1.1 0.60 
End-diastolic diameter, mm 58 ± 6 59 ± 3 0.15 
IVSD, mm 12 ± 2 13 ± 2 0.01 
IVPWD, mm 12 ± 2 12 ± 1 0.86 
End-diastolic volume, ml 122.8 ± 36.1 159.1 ± 45.7 0.02 
End-diastolic volume index, ml/m
2
 66.8 ± 22.1 85.2 ± 23.3 0.03 
End-systolic volume, ml 79.2 ± 29.5 119.6 ± 45.9 0.008 
End-systolic volume index, ml/m
2
 43.0 ± 17.2 64.2 ± 23.8 0.009 
Ejection fraction, % 35.0 ± 7.5 27.9 ± 5.8 0.005 
Relative wall thickness ratio 0.41 ± 0.07 0.40 ± 0.04 0.31 
Left ventricular mass index, g/m
2
 152.4 ± 32.6 176.1 ± 30.1 0.08 
Left atrial volume index, ml/m
2
 33.2 ± 15.0 43.9 ± 12.2 0.04 
End-diastolic LVSPHI ratio 1.40 ± 0.09 1.26 ± 0.11 0.0009 
End-systolic LVSPHI ratio 1.43 ± 0.08 1.29 ±0.07 0.0002 
HTLEF = patient study group with hypertension and low ejection fraction (<45%); IVPWD = interventricular 
posterior wall at end-diastolic dimension; IVSD = interventricular septal thickness at end-diastolic 
dimension; LVSPHI = left ventricular sphericity index; NYHA = New York Heart Association; RBR = rigid 
body rotation. 
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Figure 3.2.3    (A) Apical clockwise rotation in hypertensive patients with ejection fraction <45%. Tracking points 
at the left ventricular apical level. Left ventricular rotation–time curve (x-axis: time in ms; y-axis: left ventricular 
apical rotation in degrees). Electrocardiogram is displayed at the bottom (arrow indicates peak global apical 
rotation at time of aortic valve closure). (B) Basal rotation with normal pattern in hypertensive patients with 
ejection fraction <45%. Tracking points at the left ventricular basal level. Left ventricular rotation–time curve (x-
axis: time in ms; y-axis: left ventricular basal rotation in degrees). Electrocardiogram is displayed at the bottom 
(arrow indicates peak global basal rotation at time of aortic valve closure). 
 
A 
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TABLE 3.2.3     COMPARISON OF LEFT VENTRICULAR TWIST BETWEEN CONTROL AND HTLEF PATIENTS 
WITH NORMAL PATTERN OF TWIST 
 Control group 
(n=41) 
HTLEF group 
(n=28) 
P-value 
Apical rotation, degrees 7.15 ± 2.26 1.89 ± 0.99 <0.0001 
Basal rotation, degrees -3.75 ± 1.61 -1.44 ± 0.78 <0.0001 
Time to peak apical rotation, ms 348 ± 120 332 ± 70 0.52 
Net twist, degrees 10.90 ± 2.70 3.30 ± 1.17 <0.0001 
Untwisting rate, degrees/sec -45 ± 17 -30 ± 15 0.03 
HTLEF = patient study group with hypertension and low ejection fraction (<45%). 
 
Comparison of HTLEF patients with different patterns of twist 
 
Patients with HTLEF exhibited three different patterns of twist (normal, clockwise RBR and 
counterclockwise RBR). Since only two patients were observed to have counterclockwise RBR, 
they were not included in the analysis. There were no significant differences between the normal 
pattern and the clockwise RBR subgroups in terms of age, sex, body surface area, baseline BP and 
duration of hypertension (Table 3.2.2). NYHA class was statistically significant (p=0.017). No 
patients in the HTLEF subgroup who had clockwise RBR were NYHA class I, 64% were NYHA 
class III and 36% were NYHA class II. In contrast, 43% of patients in the HTLEF subgroup who 
had normal pattern of twist were NYHA class I, and 28% were NYHA class II or III (Table 3.2.2). 
Patients with clockwise RBR had significantly larger LV volumes (p=0.02 and p=0.008 for end-
diastolic volume and end-systolic volume, respectively), lower EF (p=0.005), and a more spherical 
LV geometry in both diastole and systole (p=0.0009 and p=0.0002, respectively) (Table 3.2.2). 
 
Correlation analysis 
 
Significant positive correlations were noted between net twist and EF (r=0.83, p<0.0001) and AR 
and EF (r=0.80, p<0.0001) in in both groups (control and HTLEF with normal pattern of twist). A 
negative correlation was seen between BR and EF in both groups (control and HTLEF with normal 
pattern of twist) (r=-0.59, p<0.0001). Subanalysis of the control group showed no significant 
correlation between LV rotation parameters and EF (AR: r=-0.02, p=0.88; BR: r=-0.19, p=0.23, net 
twist: r=0.08, p=0.60). However, there was a significant correlation between AR and EF (r=0.57, 
p=0.002) (Fig. 3.2.4, Panel A) and between net twist and EF (r=0.57, p=0.002) (Fig. 3.2.4, Panel C) 
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in the subset of the HTLEF group with normal pattern of rotation; BR showed no correlation to EF 
(r=-0.14; p=0.49) (Fig. 3.2.4, Panel B). There was no association between RWT and LV rotational 
parameters and net twist (net twist: r=0.12, p=0.58; AR: r=0.32, p=0.13; BR: r=0.24, p=0.25) in 
both groups (control and HTLEF with normal pattern of twist). There was no association between 
LVMI and net twist (r=-0.069, p=0.66 in controls; r=-0.015, p=0.94 in HTLEF with normal pattern 
of twist). Furthermore, there was no relationship between LVMI and untwist rate (r=-0.037, p=0.82 
in controls; r=-0.31, p=0.11 in HTLEF with normal pattern of twist). 
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Figure 3.2.4    Correlation between rotational parameters and ejection fraction in subgroup of 
hypertensive patients with ejection fraction <45% and normal pattern of twist (n=28). Shown are 
correlations between (A) apical rotation and ejection fraction; (B) basal rotation and ejection fraction; 
and (C) net twist and ejection fraction. 
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3.2.5  DISCUSSION 
 
In this study of patients with hypertension and low EF, we found that (a) net instantaneous twist 
and its determinants are diminished; (b) patients exhibiting RBR have more advanced LV 
dysfunction and adverse remodelling; and (c) AR and net twist correlate well with EF. 
 
This is the first study to our knowledge that has evaluated twist mechanics in HTP with low EF. 
The clinical profile of this cohort with HTLEF is unique in that all subjects had no angiographic 
evidence of epicardial coronary artery disease (CAD) and no evidence of previous myocardial 
infarction on electrocardiography, echocardiography or left ventricular angiography. This 
challenges the long-held postulate that progression to severe systolic dysfunction in patients with 
hypertension is associated with ischemia secondary to CAD or previous myocardial infarction. In 
addition, the degree of remodeling and LV dysfunction in this cohort of patients is not influenced 
by other comorbidities that may cause LV dysfunction such as diabetes, atrial fibrillation and 
volume-overloaded conditions like renal failure and anemia. Thus, hypertension is more likely to 
be the sole initiator of the remodeling process. The second important finding of this study is the 
fact that both concentric and eccentric hypertrophy were present in patients with HTLEF. 
 
Twist is determined by the rotation of the apex with respect to the base along its long axis and is 
produced by contraction of the heart’s obliquely spiraling myocardial fibre layers. Due to their 
longer radii of rotation, subepicardial fibres are thought to be the predominant cause of the net 
counterclockwise rotation at the apex and the net clockwise rotation at the base (Sengupta et al., 
2008a). We noted that diminished net twist occurred in all HTLEF patients, caused by both a 
reduction in AR and BR. However, only AR correlated positively with degree of LV dysfunction, 
suggesting degree of apical dysfunction is more important in LV dysfunction than the degree of 
basal dysfunction. The absence of ischemia or infarction in our study population is important, as 
previous studies have shown impaired AR and LV twist deformation in patients with myocardial 
infarction (Garot et al., 2002, Takeuchi et al., 2007b, Bansal et al., 2008b, Tibayan et al., 2004, 
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Nucifora et al., 2010). The reduction in both AR and BR may imply that both areas are affected by 
a more global abnormality that affects both subendocardial and subepicardial fibres. One such 
process may be microvascular ischemia, either from microcirculatory dysfunction or due to oxygen 
supply/demand mismatch. All are well documented as occurring in HTP in the absence of 
epicardial CAD. 
 
In this study we have documented RBR in patients with HTLEF for the first time. The predominant 
pattern was clockwise, implying that the apex was moving in a completely opposite direction to 
normal. In the patients with clockwise RBR, left ventricles were significantly more dilated, 
spherical and dysfunctional. We postulate that ventricular remodeling and abnormal fibre 
orientation (Beyar and Sideman, 1986) may contribute to change in the normal twist pattern. In 
severely dilated ventricles, increased LV sphericity may lead to widening of the apex resulting in 
significant changes in LV AR values (Hutchins et al., 1978, Popescu et al., 2009). Consequently, 
widening of the apex brings about the loss of the oblique architecture of the apical loop fibres, 
which become more transverse and resemble the horizontal fibre orientation of the basal loop 
(Beyar and Sideman, 1986). Thus the apex moves in a reverse direction, similar to the base, 
resulting in clockwise RBR. However, this postulate does not explain the mechanism of 
counterclockwise rotation observed in two patients. 
 
RBR and reversed systolic AR have been documented in patients with isolated LV noncompaction 
and idiopathic dilated cardiomyopathy (Hutchins et al., 1978, Popescu et al., 2009, van Dalen et al., 
2008a, Liu and Li, 2010). Some of these reports suggest patients with abnormal twist patterns have 
more severe LV remodeling than patients with normal patterns of twist (Liu and Li, 2010, Hutchins 
et al., 1978, Popescu et al., 2009, van Dalen et al., 2008a). We propose that the presence of RBR, 
especially in a clockwise direction, represents a novel assessment of more severe LV remodeling in 
HTP with LV systolic dysfunction in the absence of ischemia. The loss of LV twist may result in 
further decline in LV function and initiate a continuous, vicious cycle of remodeling. This raises 
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the question whether RBR represents a more advanced state of remodeling or if it is the precipitant 
to the development of more advanced remodeling. 
 
Study limitations 
 
Our study has a number of limitations. This study cohort represents a select population, rare in 
Western populations where comorbidities do exist. Moreover, as this study was cross-sectional, 
further follow-up and prospective research is required to determine the progression of the disease 
and long-term outcome in patients with decreased LV twist and RBR associated with hypertension 
and LV systolic dysfunction. The technique of speckle tracking utilized in this study only provides 
a two-dimensional analysis; reproducibility of these findings using other technology is uncertain. In 
addition, the gold standards of MRI tagging or sonomicrometry were not employed to confirm 
speckle-tracking findings in our study. Rotational values are lower using this specific vendor 
technology, and reproducibility of these findings using other vendors needs to be assessed. 
Further prospective studies with larger sample sizes are needed to confirm the clinical implications 
of our findings. Finally, a three-dimensional speckle-tracking analysis may offer new insight on 
patients with HTLEF and provide a good comparison with the reported findings using two-
dimensional STE. 
 
3.2.6  CONCLUSION 
 
This study provides important insight into the left ventricular twist characteristics of HTP with 
systolic dysfunction and African ancestry. We found patients with hypertension and low EF in the 
absence of coronary artery disease had reduced net twist as a result of diminished apical and basal 
rotation. RBR can occur in association with hypertension and low EF and may result in adverse 
remodelling and a greater degree of left ventricular dysfunction. 
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3.3.1  ABSTRACT 
 
Left ventricular twist may be a compensatory mechanism to preserve EF. In HTP, twist varies 
depending on the left ventricle’s degree of remodelling and systolic function; it is increased in 
those with preserved EF and diminished in those with low EF. The ratio of collagen-degradation 
biomarkers in HTP is higher in those with low EF than those with preserved EF and may contribute 
to remodelling and systolic dysfunction. This study evaluated the relationship between these 
biomarkers and left ventricular twist in 82 HTP – 41 with EF <50% (HTLEF group) and 41 with 
EF ≥50% (HTNEF group) with heart failure. Net left ventricular twist was measured using speckle-
tracking echocardiography. Markers of collagen turnover, including serum concentrations of matrix 
metalloproteinase1 (MMP1), tissue inhibitor of MMP1 (TIMP1) and ratio of MMP1:TIMP1, were 
measured. Log TIMP1, Log MMP1 and Log MMP1:TIMP1 ratio levels were higher in the HTLEF 
group versus the HTNEF group (12.32 ± 0.25 vs. 11.81 ± 0.13, p<0.0001; 9.08 ± 0.32 vs. 8.00 ± 
0.18, p<0.0001; -3.25 ± 0.30 vs. -3.81 ± 0.18, p<0.0001; respectively). Net left ventricular twist 
was lower in the HTLEF group versus the HTNEF group (3.34 ± 1.10 vs. 11.70 ± 0.67, p<0.0001). 
An inverse correlation existed between Log MMP1:TIMP1 and net left ventricular twist after 
adjusting for EF (r=-0.41, p<0.0001). This inverse correlation between twist and loss of myocardial 
collagen scaffolding suggests the integrity of the ECM plays an important role in preserving 
myocardial deformation in hypertensive patients with heart failure. 
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3.3.2  INTRODUCTION 
 
Left ventricular (LV) twist is defined as the wringing motion of the heart during systole whereby 
the apex rotates in a counterclockwise direction with respect to the base rotating in a clockwise 
direction (Helle-Valle et al., 2005, Notomi et al., 2005, Taber et al., 1996, Sengupta et al., 2008b, 
Mor-Avi et al., 2011). LV twist is an important contributing factor to the systolic function of the 
left ventricle in health and disease (Helle-Valle et al., 2005, Notomi et al., 2005, Taber et al., 1996, 
Sengupta et al., 2008b, Mor-Avi et al., 2011). Evaluation of LV twist using speckle tracking is a 
sensitive technique used to assess cardiac performance (Helle-Valle et al., 2005, Notomi et al., 
2005, Taber et al., 1996, Sengupta et al., 2008b, Mor-Avi et al., 2011) and can be a better index of 
systolic function than EF in HTP. In HTP with preserved EF, LV twist is increased while LS is 
diminished, suggesting that LV twist may be a compensatory mechanism to preserve EF (Ahmed et 
al., 2012). LV twist is diminished in HTP with low EF who initially present with HF (Maharaj et 
al., 2012a) and has been found to be more diminished in HTP with eccentric LV hypertrophy 
compared to concentric hypertrophy (Mizuguchi et al., 2010b). This suggests LV twist varies with 
the degree of remodelling and systolic function caused by hypertension. 
 
The remodelling process of the left ventricle in hypertension entails a complex interplay between 
myocyte hypertrophy and dysfunction, with qualitative changes in the ECM contributing to 
progressive dysfunction (Laviades et al., 1998, Li et al., 1998, Timms et al., 2002, Thomas et al., 
1998). Adverse LV remodelling and hypertrophy in HTP is associated with derangements in the 
dynamic balance between the accumulation and breakdown of collagen in the cardiac ECM 
(Laviades et al., 1998, Li et al., 1998, Timms et al., 2002, Thomas et al., 1998). Furthermore, 
increased matrix metalloproteinase1 (MMP1) levels – reflecting collagen degradation – may 
contribute to the development of LV dilatation and failure in HTP matrix (Laviades et al., 1998, Li 
et al., 1998, Timms et al., 2002, Thomas et al., 1998, López et al., 2006). (López et al., 2006) found 
that a greater excess of MMP1 to the tissue inhibitor of matrix metalloproteinase1 (TIMP1) 
occurred in the myocardium of HTP with low EF than those with normal EF. Moreover, Lopez et 
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al. found that the circulating MMP:TIMP ratio was associated with greater LV dilatation and 
systolic dysfunction (López et al., 2006). This landmark study implied the varying morphology and 
function in HHD was related to the equilibrium of MMP1 and TIMP1 in maintaining collagen 
homeostasis (López et al., 2006).  Hypertension can cause systolic dysfunction as a consequence of 
adverse remodelling and LV hypertrophy, but given the multitude of factors involved in LV 
decompensation mediated by mechanical, neurohormonal and cytokine routes, the exact 
mechanisms that contribute to the adverse remodelling and EF deterioration are not fully elucidated 
(Drazner, 2011, Frohlich, 1999). 
 
We postulate that changes in the ECM as reflected by MMP1:TIMP1 ratio account for the varying 
morphology, EF and LV twist in HTP who present with HF. The aim of this study was to evaluate 
LV twist mechanics and their relationship with biomarkers of collagen degradation in HTP. 
 
3.3.3  METHODS 
 
This cross-sectional study was approved by the University of Witwatersrand Ethics Committee and 
the Institutional Review Board. Subjects were consecutively recruited from the Chris Hani 
Baragwanath Hospital Cardiac Clinic from January 2011 to June 2012. Inclusion criteria were: 
documented prior diagnosis of hypertension (measurements on three separate occasions where 
systolic BP was ≥140 mmHg or diastolic BP was ≥90 mmHg taken over a period of two months 
(Seedat and Rayner, 2012) at the Hypertension Clinic), documented HF using Framingham Study 
criteria (Lloyd-Jones et al., 2002), sinus rhythm, and normal coronary angiography. Exclusion 
criteria were: previous myocardial infarction, previous arrhythmia, anaemia (haemoglobin <12 
g/dL in females, <13 g/dL in males), excess alcohol intake (maximum alcohol intake no more than 
40 grams per day in males and 20 grams per day in females with two alcohol-free days per week), 
renal dysfunction (glomerular filtration rate <60 mL/min/1.73 m
2
), documented diagnosis of 
diabetes and/or glycated haemoglobin >7%, organic valvular disease, dilated cardiomyopathy of 
any etiology, cardiac infiltrative diseases, post-viral myocarditis, any systemic illness (e.g. human 
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immunodeficiency virus [HIV]), thyroid disease, any primary organ dysfunction or failure (e.g. 
chronic renal disease), and patients with evidence of RBR on speckle tracking. 
 
A total of 107 subjects who fulfilled the criteria and provided voluntary informed consent were 
enrolled and underwent a detailed clinical and echocardiographic evaluation at baseline. After 
echocardiography, 25 patients were excluded as a result of inadequate image quality that did not 
allow for complete segmental assessment of LV rotation at both the basal and apical left ventricle. 
The remaining 82 HTP, 41 of whom had EF <50% (HTLEF group) and 41 of whom had EF ≥50% 
(HTNEF group), made up the study group and were given adequate doses of HF therapy as per 
individual patient’s requirements. 
 
The control group (n=41) was recruited from staff at Chris Hani Baragwanath Hospital, patient 
escorts and community members from Soweto. All controls were unrelated to patients in the study 
groups and were asymptomatic, normotensive, had no evidence of cardiovascular or systemic 
disease, and had a normal 12-lead electrocardiogram prior to undergoing echocardiography for the 
study. The control group was age- and sex-matched with the HTLEF and HTNEF cohorts. 
Individuals younger than 50 years were matched with a tolerance of 5 years in terms of age, 
whereas individuals older than 50 years were allowed a tolerance of up to 10 years. 
 
BP measurements 
 
Please refer to 3.1.3. 
 
Echocardiography 
 
Please refer to 3.1.3. Concentric hypertrophy was defined as RWT >0.42 and left ventricular mass 
index (LVMI) (g/m
2
) >95 in females and >115 in males, while eccentric hypertrophy was defined 
as RWT <0.42 and LVMI >95 in females and >115 in males (Lang et al., 2005, Ganau et al., 1992). 
LV sphericity index was calculated by dividing the LV maximal long-axis internal dimension by 
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the maximal short-axis internal dimension at end diastole and end systole (van Dalen et al., 2010) 
using apical four-chamber view. 
 
Speckle-tracking analysis 
 
Please refer to Methods in chapter 3.2.3.  
 
Biomarkers 
 
All blood samples were taken at the time of echocardiographic examination. Samples were 
collected in a serum separator tube, which allowed samples to clot for 30 minutes before 
centrifuging for 15 minutes at 1000 × gravity. Serum was removed immediately and samples stored 
at less than or equal to -20°C. Total serum levels of TIMP1 and MMP1 were determined using the 
Fluorokine
®
 MAP multiplex kits (R&D Systems, Minneapolis, MN) designed for use with the 
Luminex
®
 100 dual-laser, flow-based analyzers (Luminex Corp., Austin, TX), which detect 
antibodies to human TIMP1 and MMP1. The inter- and intra-assay coefficients of variation were 
12.7% and 5.9% for MMP1 and 10.1% and 6.5% for TIMP1, respectively. Lower detection limits 
were 4.40 pg/ml of MMP1 and 1.54 pg/ml of TIMP1. Because the actual activity of MMP1 
depends on the balance between active enzyme and inhibitor (i.e. TIMP1), the serum 
MMP1:TIMP1 ratio was considered an index of MMP1 activity. 
 
Statistical Analysis 
 
Database management and analyses were performed with SAS software (Version 9.2, SAS Institute 
Inc., Cary, NC). Data was presented as mean ± standard deviation. Continuous variables between 
groups were compared using ANOVA, or Kruskal-Wallis test when the distribution was non-
normal. Two-by-two comparisons were then performed applying Bonferroni correction with 
p<0.0083 denoting significance. Biomarker levels (TIMP1, MMP1 and MMP1:TIMP1 ratio) were 
log-transformed before analysis when distribution was non-normal. Pearson correlation coefficients 
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were determined for the relationships between LV myocardial deformation parameters and 
biomarker levels. Interobserver variability was assessed for twist and strain measurements in 20 
randomly selected patients and calculated as the standard deviation of the differences between 
measurements of two independent observers who were unaware of the other patient data, then 
expressed as a percentage of the average value. Intraobserver variability was calculated as the 
standard deviation of the differences between a first and second determination of a single observer, 
and expressed as a percentage of the average value. Intra- and interobserver variability for LV 
rotation parameters in our centre varies from 2 ± 3% to 10 ± 9%, and from 4 ± 4% to 12 ± 8%, 
respectively (Maharaj et al., 2012b). 
 
3.3.4  RESULTS 
 
Baseline and Echocardiographic Characteristics 
 
There were no statistically significant differences in age, sex or body mass index between the 
HTLEF and HTNEF groups (p>0.05) (Table 3.3.1). Mean duration of hypertension was similar 
between the two groups (12.2 ± 6.5 years in HTLEF and 15.5 ± 8.4 years in HTNEF, p>0.05) 
(Table 3.3.1), but mean duration of HF was higher in the HTLEF group (3.2 ± 1.6 years) than the 
HTNEF group (1.8 ± 1.0 years), p<0.005. All patients in the HTLEF group had LV hypertrophy 
compared with 85% in the HTNEF group. The HTLEF group had significantly higher LV mass 
index and end-diastolic volume index and lower sphericity index (p<0.01) (Table 3.3.2). 
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TABLE 3.3.1.     CLINICAL CHARACTERISTICS COMPARISON BETWEEN CONTROLS AND HYPERTENSIVE 
PATIENTS 
 Control Group HTNEF Group HTLEF Group 
No. patients 41 41 41 
Age, years 50.1±9.3^ 55.5±8.4 55.0±9.1* 
Gender, F:M 22:19 22:19 22:19 
Body mass index, kg/m
2
 24.7±1.8^ 30.2±4.9 28.9±4.2
#
 
Body surface area, m
2
 1.72±0.14^ 1.86±0.15 1.85±0.16
#
 
NYHA functional capacity, no. (%) 
Class I 
Class II 
Class III 
 
41 (100%) 
 
26 (63%)
##
 
15 (37%) 
 
 
12 (29%)
#
 
14 (34%) 
15 (37%) 
Duration of hypertension, years --- 15.5±8.4 12.2±6.5 
Duration of heart failure, years --- 1.8±1.0
##
 3.2±1.6 
Systolic blood pressure, mmHg 128±10^ 141±14
##
 156±8
#
 
Diastolic blood pressure, mmHg 79±8 84±11 89±10
#
 
Heart rate, bpm 73±10 75±11
##
 81±10
#
 
Medication, no. (%) 
Furosemide 
ACE-I or ARB 
Beta blockers 
Amlodopine 
Spironolactone 
 
0 
0 
0 
0 
0 
 
41 (100%) 
41 (100%) 
28 (68%) 
41 (100%) 
0 
 
41 (100%) 
41 (100%) 
41 (100%) 
41 (100%) 
41 (100%) 
Values are mean ± standard deviation. 
#
p<0.001 for comparison among all groups; *p=0.03 for age among 
all groups; 
##
p<0.005 for comparison between HTNEF and HTLEF. ^p<0.001 for comparison between 
controls and HTNEF. ACE-I indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor 
blocker; F:M, female-to-male ratio of number of patients; HTLEF, patient study group with hypertension and 
low ejection fraction (<50%); HTNEF, patient study group with hypertension and normal ejection fraction 
(≥50%); NYHA, New York Heart Association. 
 
 
TABLE 3.3.2.     ECHOCARDIOGRAPHIC DATA COMPARISON BETWEEN CONTROLS AND HYPERTENSIVE 
PATIENTS 
 Control Group HTNEF Group HTLEF Group 
No. patients 41 41 41 
End-diastolic diameter, mm 43±5 45±1
##
 58±5
#
 
IVSD, mm 10±1^ 13±2
##
 12±2
#
 
IVPWD, mm 8±1^ 10±1 11±1
#
 
End-diastolic volume index, ml/m
2
 46.8±7.7 45.5±13.8
##
 71.7±21.6
#
 
End-systolic volume index, ml/m
2
 18.9±5.6 18.4±7.3
##
 47.1±17.0
#
 
Ejection fraction, % 69.3±9.5^ 60.9±7.3
##
 33.4±7.1
#
 
Left ventricular mass index, g/m
2
 73.8±13.9^ 106.3±21.3
##
 152.0±25.3
#
 
Left atrial volume index, ml/m
2
 23.0±2.2^ 26.8±3.8
##
 31.0±16.3
#
 
LVSPHI (end diastole), ratio 1.9±0.3^ 1.7±0.1
##
 1.4±0.1
#
 
LVSPHI (end systole), ratio 2.1±0.5^ 1.8±0.2
##
 1.4±0.1
#
 
E/E` ratio 5.6±1.8^ 11.6±4.6
##
 18.7±12.1
#
 
Values are mean ± standard deviation. 
#
p<0.001 for comparison among all groups; 
##
p<0.01 for comparison 
between HTNEF and HTLEF. ^p < 0.001 for comparison between controls and HTNEF.
 
 HTLEF indicates patients with hypertension and ejection fraction <50% on echocardiography; HTNEF, 
patients with hypertension and ejection fraction ≥50% on echocardiography; IVPWD, interventricular 
posterior wall at end-diastolic dimension; IVSD, interventricular septal thickness at end-diastolic dimension; 
LVSPHI, left ventricular sphericity index. 
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Myocardial Deformation and Biomarkers Analysis 
 
Net LV twist was significantly higher in the HTNEF group (11.70° ± 0.67) compared to controls 
(10.9° ± 2.7) and the HTLEF group (3.34° ± 1.10) [p<0.001] (Table 3.3.3). AR was higher in the 
HTNEF group than in controls (p<0.001), while BR was similar (p=0.36) (Table 3.3.3). AR and 
BR values were significantly higher in HTNEF compared with HTLEF (p<0.0001) (Table 3.3.3). 
Longitudinal, circumferential and RSwere diminished in the HTNEF and HTLEF groups compared 
with controls, with a greater decrement in the HTLEF group (p<0.0001) (Table 3.3.3). Log TIMP1, 
Log MMP1 and Log MMP1:TIMP1 ratio were increased in HTLEF compared with HTNEF (12.32 
± 0.25 vs. 11.81 ± 0.13; 9.08 ± 0.32 vs. 8.00 ± 0.18; and -3.25 ± 0.30 vs. -3.81 ± 0.18, p<0.0001; 
respectively) (Table 3.3.3). 
 
 
TABLE 3.3.3    MYOCARDIAL DEFORMATION AND BIOMARKERS COMPARISON BETWEEN CONTROLS AND 
HYPERTENSIVE PATIENTS 
 Control Group HTNEF Group HTLEF Group 
No. patients 41 41 41 
Apical rotation, degrees 6.8±1.5^ 7.7±0.4
##
 1.7±1.0
#
 
Basal rotation, degrees -3.8±1.6 -4.0±0.6
##
 -1.6±0.9
#
 
Time to peak apical rotation, ms 348±20 356±14
##
 326±6* 
Net twist, degrees 10.6±2.3^ 11.7±0.7
##
 3.3±1.1
#
 
Untwisting rate, degrees/s -50.6±4.3^ -39.1±3.4
##
 -26.8±6.4
#
 
Longitudinal strain, % -14.6±2.2^ -11.4±0.2
##
 -8.7±1.2
#
 
Circumferential strain,% -14.6±2.3^ -11.5±0.3
##
 -9.0±1.4
#
 
Radial strain, % 54.6±2.3^ 42.2±2.4
##
 29.0±1.3
#
 
TIMP1, pg/ml 86240.2±12405.2^ 135969.3±20767.1
##
 232612.2±66117.2
#
 
Log TIMP1 11.4±0.1^ 11.8±0.1
##
 12.3±0.3
#
 
MMP1, pg/ml 894.8±213.1^ 3036.8±553.7
##
 9203.1±2981.0
#
 
Log MMP1 6.8±0.2^ 8.0±0.2
##
 9.1±0.3
#
 
MMP1:TIMP1 ratio 0.011±0.003^ 0.023±0.004
##
 0.041±0.014
#
 
Log MMP1:TIMP1 ratio -4.6±0.3^ -3.8±0.2
##
 -3.3±0.3
#
 
Values are mean ± standard deviation. 
#
p<0.0001 for comparison among all groups;
 
*p<0.01 for comparison 
among all groups; 
##
p<0.005 for comparison between HTNEF and HTLEF. ^p<0.001 for comparison between 
controls and HTNEF.
 
 HTLEF indicates patients with hypertension and ejection fraction <50% on echocardiography; HTNEF, patients 
with hypertension and ejection fraction ≥50% on echocardiography; MMP1, matrix metalloproteinase-1; TIMP1, 
tissue inhibitor of matrix metalloproteinase-1. 
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Relationship between Biomarkers and LV Twist 
 
As longitudinal and CS and BR decreased (increasing to a positive value), Log MMP1:TIMP1 ratio 
increased in the HTNEF and HTLEF groups (Table 3.3.4). Log MMP1:TIMP1 ratio inversely 
correlated with net LV twist and EF (r=-0.74, p<0.0001; r=-0.67, p<0.0001, respectively) in HTP 
(Table 3.3.4). However, after adjusting for EF, Log MMP1:TIMP1 ratio explained 16.8% of the net 
LV twist variation (p<0.0001) (Table 3.3.4). 
 
 
Table 3.3.4 Correlation of Log MMP1:TIMP1 With Myocardial Deformation 
Parameters in Hypertensive Patients 
 Unadjusted Adjusted for  
ejection fraction 
Ejection fraction, % r=-0.67 
p<0.0001 
--- 
Twist, degrees r=-0.74 
p<0.0001 
r=-0.41 
p<0.0001 
Apical rotation, degrees r=-0.74 
p<0.0001 
r=-0.40 
p=0.0002 
Basal rotation, degrees r=0.64 
p<0.0001 
r=0.30 
p=0.006 
Longitudinal strain, % r=0.53 
p<0.0001 
r=0.08 
p=0.50 
MMP1:TIMP1 indicates ratio of matrix metalloproteinase-1 to tissue inhibitor 
of matrix metalloproteinase-1. 
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3.3.5  DISCUSSION 
 
This study’s main findings were: 1) LV twist is increased in HTNEF patients, whereas all other 
strain parameters are diminished compared with controls; 2) In HTLEF patients, LV twist is 
decreased while all strain parameters are diminished to a greater extent than that observed in 
HTNEF patients; 3) Circulating biomarkers of collagen turnover are increased to a greater degree 
in HTLEF patients than in HTNEF patients; and 4) There is a modest inverse correlation between 
LV twist and Log MMP1:TIMP1 ratio even when adjusted for EF. 
 
LV twist originates from the dynamic interaction between oppositely wound subepicardial and 
subendocardial myocardial fibre helices and has an important role in LV ejection (Sengupta et al., 
2008b). The contraction of the subepicardial fibres rotates the apex in a counterclockwise direction 
and the base in a clockwise direction. The contraction of the subendocardial region rotates the apex 
and base in exactly the opposite directions (Sengupta et al., 2008b). When both layers contract 
simultaneously, a larger radius of rotation for subepicardial fibres results in a mechanical advantage 
determining the overall direction of rotation at apex (counterclockwise) and base (clockwise) 
(Sengupta et al., 2008b). 
 
This study confirms that LV twist varies with the degree of remodelling and dysfunction in HHD, 
with similar abnormalities reported in prior studies of HTP with either normal or low EF (Maharaj 
et al., 2012a, Mizuguchi et al., 2010b, Ahmed et al., 2012). Studies (Maharaj et al., 2012a, 
Mizuguchi et al., 2010b, Ahmed et al., 2012, van Dalen et al., 2010, Garot et al., 2002, Takeuchi et 
al., 2007b) show a positive correlation between LV twist and EF, reflecting that reduction in LV 
systolic function is accompanied by reduction of twist. In HTP with normal EF, LS decreases while 
an increment in LV twist ensures preservation of normal EF (Maharaj et al., 2012a, Mizuguchi et 
al., 2010b, Ahmed et al., 2012). HTNEF patients have less adverse remodelling; consequently their 
subendocardial and subepicardial fibres are less affected. Thus, while there is a decline in all strain 
modalities compared with controls, LV twist increases to preserve EF in these patients(Maharaj et 
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al., 2012a, Mizuguchi et al., 2010b, Ahmed et al., 2012), especially those with preserved apical 
function. However, LV twist is decreased in HTP with low EF, in keeping with the overall decrease 
in other strain parameters. The major mechanism for this appears to relate to apical function 
(Maharaj et al., 2012a, Mizuguchi et al., 2010b, Ahmed et al., 2012). A prior study depicted that 
AR correlated positively with the degree of LV dysfunction, suggesting degree of apical 
dysfunction is more important than the degree of basal dysfunction (Maharaj et al., 2012a, 
Mizuguchi et al., 2010b, Ahmed et al., 2012). The absence of ischemia or infarction in our study 
population is important, since these confounding factors may decrease apical function and, 
consequently, LV twist (Takeuchi et al., 2007b, Bansal et al., 2008b, Tibayan et al., 2004, Nucifora 
et al., 2010). It cannot be ascertained whether the difference in LV twist observed in normal versus 
low EF represents a cause or consequence of a decline in EF in hypertensive-associated HF. 
 
The second finding of this study is that circulating biomarkers of collagen are elevated to a greater 
degree – with decrements in myocardial deformation – in HTP with low EF compared to those with 
normal EF. These findings are similar to those documented by (López et al., 2006) who 
demonstrated an excess of MMP1 relative to TIMP1 in the myocardium of HTP with low EF 
compared with those with preserved EF in 39 patients with no coronary artery disease (16 with low 
EF, 23 with preserved EF). Their study documented that HTP with low EF had a lower volume of 
myocardial tissue occupied by endomysial and perimysial collagen but increased perivascular and 
scar-related collagen deposits compared with HTP with normal EF (López et al., 2006). They also 
found that the serum MMP1:TIMP1 ratio was inversely correlated with EF, whereas the degree of 
LV dilatation was positively correlated (López et al., 2006). Thus, the phenotype of LV dilatation 
associated with reduced EF may be a consequence of this remodelling that occurs in the ECM due 
to excessive MMP1 activity relative to TIMP1. 
 
Our study shows an inverse relationship between MMP1:TIMP1 ratio and LV twist even when 
adjusting for EF, implying that the decline in LV twist may be related to the remodelling process of 
the ECM. HTP with normal EF have lower MMP1:TIMP1 ratios, suggesting less extracellular 
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remodelling that does not affect all regions of the myocardium to the same extent. Prior studies 
have suggested the major pathophysiological abnormality in HTNEF patients is that of 
subendocardial ischemia (Fujii et al., 1992), which occurs in the absence of coronary disease and 
initially affects subendocardial fibres (Kang et al., 2008). Subendocardial ischemia results from 
diminished coronary flow autoregulation in the subendocardium compared to the subepicardium 
with increased transmural pressure loss within the microvasculature contributing to subendocardial 
underperfusion and vulnerability to ischemic injury (Fujii et al., 1992). 
 
In HTP with normal EF, the degree and location of collagen degradation may relate to the 
myocardial deformation indices, i.e. interstitial and perivascular fibrosis and collagen degradation 
is likely to initially affect the subendocardial fibres in the presence of subendocardial ischemia 
(Kang et al., 2008), with decrement in LS due to their prominent subendocardial location (Kang et 
al., 2008), and thereafter the development of circular fibre dysfunction in the midwall (decreases in 
radial and CS) (Kang et al., 2008). If the greatest area of involvement is the subendocardium and 
perhaps some degree of involvement in the midmyocardium, then LS will be most affected with 
varying decrements of circumferential and RS noted. Subendocardial fibre dysfunction will cause 
less opposition to the subepicardial fibres, thus the predominant rotatory effects of the 
subepicardial fibres dominate during systole and result in enhanced BR, AR and net LV twist. In 
our study, this postulate would explain the strain, AR and net LV twist observed in HTNEF. A 
nonsignificant trend of increased BR also was noted. 
 
Higher MMP1:TIMP1 ratio was detected in HTP with low EF compared with HTNEF patients. 
This finding is similar to (López et al., 2006) and suggests this process is characterized by more 
extensive extracellular remodelling. We propose that perhaps this adverse remodelling is a more 
diffuse process that affects all regions of the myocardium to a similar degree, such that the 
relatively preserved subepicardial fibre function seen in HTNEF is abolished, resulting in 
impairment of all myocardial strain and LV twist. As collagen degradation increases, there is global 
dysfunction of both the subendocardial and subepicardial fibres, with diffuse collagen degradation 
 
 
- 81 - 
 
in subepicardial and subendocardial fibres resulting in greater impairment in AR and LV twist. This 
accompanies greater decrements in strain parameters in HTP with low EF. 
 
The decline in LV twist may relate both to factors that cause a global reduction in systolic function 
and specific remodelling factors that decrease LV twist. The loss or disruption of this collagen 
network may compromise systolic function by three mechanisms. Firstly, the loss of mysial 
collagen results in discontinuity of the ECM, compromising the alignment and support of the 
matrix (López et al., 2006). A second factor relates to the possible loss of synchronized sarcomere 
contraction (López et al., 2006). The final mechanism occurs as a consequence of increased MMP1 
activity where there is myocardial slippage and, consequently, a decreased number of muscle layers 
in the left ventricle (López et al., 2006). Collagen loss promotes myocyte slippage, thereby altering 
LV structure and function with ventricular dilatation, increasing LV sphericity and greater systolic 
dysfunction if the process is exaggerated (Laviades et al., 1998, Li et al., 1998, Timms et al., 2002, 
Thomas et al., 1998, López et al., 2006). The loss of the oblique architecture of loop fibres and 
abnormal muscle fibre orientation (Popescu et al., 2009) responsible for the wringing motion 
results in a decline in LV twist (van Dalen et al., 2010). 
 
Limitations 
 
This study cohort represents a select population, rare in Western populations where comorbidities 
do exist. Speckle-tracking echocardiography software used only provides a two-dimensional 
analysis, and the consistency of these findings using other two-dimensional vendor technology is 
uncertain. Tagged MRI or sonomicrometry were not employed as the gold standard to compare 
speckle-tracking findings. We did not histologically investigate the correlation between 
echocardiographic parameters and the collagen volume fraction in myocardium or assessment of 
tissue MMP activity (i.e. zymography). Moreover, as this study was cross-sectional with a small 
sample size, further follow-up and prospective research is required to determine how the changes in 
LV twist, extracellular collagen degradation and remodelling affect progression of HHD. 
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3.3.6  CONCLUSION 
 
HTP with low EF have more collagen degradation and impaired twist compared to HTP with 
normal EF. Log MMP1:TIMP1 ratio inversely correlates with net LV twist even when adjusted for 
EF. These preliminary findings may indicate that increased loss of myocardial collagen scaffolding 
not only accompanies more adverse remodelling but also contributes to the differences in LV twist 
mechanics observed between HTLEF and HTNEF patients. Alterations in collagen turnover can 
affect the oblique spiral myocardial fibre architecture, resulting in abnormalities in LV twist 
mechanics. 
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4.0 DISCUSSION 
 
4.1 SUMMARY OF KEY FINDINGS 
 
Firstly, this study established normative data and patterns for myocardial deformation (strain and 
LV twist) in a normal black-African adult population across different age groups and can be used 
as a baseline for future studies. Aging was associated with increased net LV twist whilst decreasing 
strain parameters were associated with advancing age. Age was the major determinant of increased 
LV twist in this population. Additionally, despite an increase in relative wall thickness, left 
ventricular mass index, systolic BP and changes in diastolic indices with advancing age in our 
study, conventional echocardiographic and clinical variables were not able to predict net LV twist. 
Moreover, strain parameters showed an independent correlation (longitudinal, circumferential and 
radial strain) with net LV twist but were unable to predict net LV twist. 
 
Secondly, diminished net twist occurred in all HTLEF patients, caused by both a reduction in AR 
and BR. However, only AR correlated positively with the degree of LV dysfunction, suggesting 
that the degree of apical dysfunction is more important in LV dysfunction than the degree of basal 
dysfunction. AR and net twist correlate well with EF whilst end diastolic diameter showed no 
correlation with LV twist. RBR can occur in association with hypertension and low EF and may 
result in adverse remodelling and a greater degree of left ventricular dysfunction. 
 
Finally, all strain parameters are diminished in HTNEF and HTLEF while LV twist is increased in 
HTNEF compared to HTLEF patients.  LV twist varies with the degree of remodelling and 
dysfunction in HHD. This study revealed an inverse relationship between MMP1:TIMP1 ratio and 
LV twist even when adjusting for EF, implying that the decline in LV twist may be related to the 
remodelling process of the ECM. HTP with low EF have more collagen degradation and impaired 
twist compared to HTP with normal EF. These preliminary findings may indicate that increased 
loss of myocardial collagen scaffolding not only accompanies more adverse remodelling but also 
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contributes to the differences in LV twist mechanics observed between HTLEF and HTNEF 
patients. Alterations in collagen turnover can affect the oblique spiral myocardial fibre architecture, 
resulting in abnormalities in LV twist mechanics. 
 
4.2 MYOCARDIAL DEFORMATION IN NORMAL ADULTS 
 
STE provides assessment of cardiac chamber function through the largely angle independent 
quantification of LV myocardial deformation (Bohs and Trahey, 1991). The routine use of 2D 
strain and LV twist in clinical practice requires the definition of a normal range, but the majority of 
studies have defined their own normal ranges using a relatively small number of subjects who are 
of a limited age range. Our study provides the age specific normal range of 2D strain and LV twist 
parameters which serve as reference for the parameters measured to investigate changes that may 
occur in disease states in an African population.  
 
Our findings reveal that the values of BR, AR and net twist using the QLAB software do not differ 
from findings in other populations using this vendor’s technology (van Dalen et al., 2008b). 
Additionally, the values obtained for AR and BR in this study are less than those reported in 
normal populations using different vendor technologies (van Dalen et al., 2008b, Zhang et al., 
2007, Zhang et al., 2010, Takeuchi et al., 2006). The mean strain values in our study were -17.28 ± 
3.30% for longitudinal, -17.40 ± 3.29% for circumferential and 57.49 ± 3.32% for radial strain. 
Marwick et al reported an average LV peak systolic LS of –18.6 in 242 healthy volunteers using a 
General Electric (GE) system (Marwick et al., 2009). Another recent report described an average 
global LS of –20.6±2.6% and an average RS of 48.2±13.8% in 144 healthy subjects using a GE 
system (Reckefuss N, 2011). The average values of longitudinal and CS were also significantly 
lower in Caucasians than in Asians. This difference is thought to be related to body surface area, 
which is significantly higher in Caucasians than in Asians.  
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Few studies have addressed the inter-vendor variability of 2D strain measurements (Bansal et al., 
2008a, Biaggi et al., 2011, Koopman et al., 2010, Manovel et al., 2010). A recent study  performed 
2D speckle tracking analysis on 28 healthy adult subjects using ultrasound systems and software 
from GE and Toshiba, and found no significant vendor differences in the global longitudinal, 
circumferential or RS measurements (Manovel et al., 2010). They also reported that global LS had 
a more narrow limit of agreement (–2.25 to 3.65) compared to radial and CS and concluded that 
global LS is a more robust parameter for evaluating myocardial function when a different cardiac 
ultrasound system is used for assessment (Manovel et al., 2010).  
 
Although the fundamental concept of 2D STE may be the same, 2D STE image tracking ability on 
a frame-by-frame basis in 3 vendors was different, resulting in a maximum difference of 18% in the 
feasibility between vendors (Takigiku et al., 2012). Image quality could affect the tracking 
feasibility observed in all of the systems from the different vendors (inferior in the Philips system 
compared to the GE or Toshiba) (Takigiku et al., 2012). Therefore, it must be acknowledged that 
the contribution of image quality to tracking feasibility differs with vendors and as a result the 
normal range of 2D strain differs (Takigiku et al., 2012). Systems from different vendors are not 
interchangeable when acquiring and analyzing 2D strain data to assess myocardial deformation 
from the same subjects (Takigiku et al., 2012).  
 
Physiological variables such as preload, afterload, and contractility alter the extent of LV twist 
(Dong et al., 1999, Hansen et al., 1991, MacGowan et al., 1996). Twist is greater with higher 
preload. For example, higher LV end-diastolic volumes, with LV end-systolic volume held 
constant, produce higher LV twist (Sengupta et al., 2008b). Similarly, afterload affects twist, that 
is, twist decreases at higher end-systolic volumes when end-diastolic volumes are held constant 
(Sengupta et al., 2008b). The effect of preload on twist is about two-thirds as great as that of 
afterload. Like changes in loading conditions, increasing contractility increases LV twist; for 
example, positive inotropic interventions such as dobutamine infusion and paired pacing increase 
LV twist (Buchalter et al., 1994, Moon et al., 1994, Hansen et al., 1991), whereas negative 
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inotropic interventions markedly reduce twist (Buchalter et al., 1994). In the intact circulation, 
changes in contractility are often accompanied by changes in loading conditions, thus, altering LV 
twist mechanics (Sengupta et al., 2008b).  
 
4.3 EFFECT OF AGING ON MYOCARDIAL DEFORMATION 
 
The increasing number and proportion of aged individuals in the population warrants knowledge of 
normal physiological changes of myocardial deformation with advancing age. Aging affects many 
aspects of cardiovascular function (Lakatta, 2003c, Lakatta, 2003a, Lakatta, 2003b, Lakatta and 
Sollott, 2002, Oxenham et al., 2003). Advancing age is associated with structural and functional 
changes in the myocardium, e.g. myocardial fibrosis and impaired coronary perfusion (Oxenham et 
al., 2003, Lakatta, 2003c, Lakatta, 2003a, Lakatta, 2003b). Increased LV wall thickness, alterations 
in the diastolic filling pattern, impaired LV ejection and heart rate reserve capacity are the most 
dramatic changes in cardiac function that occur with aging in healthy persons (Lakatta, 2003c, 
Lakatta, 2003a, Lakatta, 2003b). Although these age-associated changes do not always reflect 
clinical heart disease per se, they may compromise cardiac reserve and alter the threshold for 
disease manifestation. 
 
Age-related changes is via changes in sarcomere protein isoforms and titin development which 
alters myocardial contractility (Lakatta et al., 1975, Lakatta, 2003a). In addition, BP increases with 
aging, but the proportions of LV shape and ventricular wall thickness and size remained constant, 
which causes increased interventricular wall strain and drives the changes in LV myocardial 
deformation (Lakatta, 2003c, Lakatta, 2003a).  
 
The characteristics of LV twist undergo substantial changes during the aging process. Our findings 
observed that AR increased substantially after age 40 whereas no significant increment occurred in 
BR after age 40. In accordance with our study, BR also was less influenced by age in other 
published data (van Dalen et al., 2008b, Zhang et al., 2007, Takeuchi et al., 2006, Zhang et al., 
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2010). Van Dalen et al. reported a mean value of peak LV twist as 7.7 ± 3.58° in a white population 
(van Dalen et al., 2008b), with peak LV twist significantly greater in subjects aged ≥60 years (10.8 
± 4.98°) compared with those aged ≤40 years (6.7 ± 2.98°) and those aged 41 to 59 years (8.0 ± 
3.08°) (van Dalen et al., 2008b). Takeuchi et al. examined the effect of aging on twist in 113 Asian 
volunteers; peak LV twist increased significantly in those aged ≥60 years with similar values as 
published on whites (Takeuchi et al., 2006). Furthermore, (Zhang et al., 2010) showed a greater 
increment in AR from subjects aged 45 to 55 years (7.94 ± 1.20°) to those aged 55 to 65 years (9.65 
± 1.56°), and a lesser increase in BR [-6.50 ± 2.49° (45-55 years) vs. -7.07 ± 1.25° (55-65 years)]. 
 
The increase in LV twist can be partially explained by reduced opposition to AR, which results 
from a gradual decrease in subendocardial function with aging (Zhang et al., 2010, van Dalen et al., 
2008b, Takeuchi et al., 2006, Zhang et al., 2007). In a tagged MRI study, aging was associated with 
a decrease of contractile function in the sub-endocardium relative to that in the sub-epicardium 
without changes in EF (Lumens et al., 2006). Impairment of subendocardial contractile function 
may be on the basis of ischemia or fibrosis and results in diminished clockwise systolic BR, which 
leads to less opposition of counterclockwise systolic AR, causing net twist to increase (Zhang et al., 
2007, Zhang et al., 2010, van Dalen et al., 2008b, Takeuchi et al., 2006).
 
Subendocardial 
dysfunction develops with aging due to subendocardial fibrosis and fibre rearrangement reducing 
negative torque in the subendocardium, causing augmentation of positive myocardial twist.  The 
net effect is increased LV twist and the preservation of EF in the elderly and reducing myocardial 
oxygen demand (Tibayan et al., 2004, Taber et al., 1996). 
 
 
An analysis of other aspects of myocardial mechanics revealed a concurrent reduction in 
longitudinal, circumferential and RS with increasing age. Whereas some researchers described 
reduced strain with increasing age (tissue Doppler imaging (Dalen et al., 2010, Kuznetsova et al., 
2008) and
 
MRI (Fonseca et al., 2003)) or increasing strain with aging (STE) (Reckefuss N, 2011), 
others found no correlation between strain and age (tissue Doppler imaging) (Sun et al., 2004) in 
other populations. Moreover, some studies using speckle tracking found some strain parameters 
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(circumferential and radial strain) increased (Sun et al., 2012a, Reckefuss N, 2011) while LS 
decreased (Sun et al., 2012a).  
 
LV systolic twist gradually increases from infancy to adulthood (Burns et al., 2008, Sengupta et al., 
2008b, Esch and Warburton, 2009). LV systolic twist continues to increase with aging as a result of 
increased AR. AR is the major contributing factor of LV twist, with an increase in AR resulting in 
an increase in twist. This implies that apical function is perhaps the most important determinant for 
LV twist, and one would expect that pathological states that impair apical function to a greater 
degree than other anatomic sites may result in greater LV dysfunction. In this study age remained 
the main independent predictor of net LV twist.  
 
4.4 MYOCARDIAL MECHANICS IN HYPERTENSIVE PATIENTS WITH PRESERVED 
EF  
 
The deleterious effects of hypertension on LV function are multifactorial, comprising increased 
mechanical stress with subsequent LV hypertrophy, alterations in the phenotype of cardiomyocytes, 
enhanced apoptosis of the cardiomyocytes with interstitial and perivascular fibrosis, endothelial 
dysfunction, microvascular insufficiency, and upregulation of neurohormonal factors, such as the 
sympathetic and renin-angiotensin-aldosterone system (de Leeuw and Kroon, 1998, Fouad, 1987). 
Many pathophysiological mechanisms, including reductions in coronary blood flow reserve 
(CBFR), have been proposed to explain the progression of compensated LVH to ventricular 
dysfunction (Frohlich, 1999). Coronary microcirculation alterations in hypertension have already 
been reported in a previous study (Hamasaki et al., 2000). Endothelial dysfunction in hypertension 
has been shown in coronary vasculature in patients without LV systolic dysfunction (Hamasaki et 
al., 2000, Treasure et al., 1993). It is possible that impairment of endothelium-dependent coronary 
vasodilatation capacity is one of the mechanisms responsible for inadequate myocardial flow, and 
therefore contributes to ventricular maladaptation before the development of morphological 
alterations.  
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The results of large epidemiologic trials indicate that hypertension is one of the key factors 
associated with the increased incidence of congestive HF (Levy et al., 1996). Both structural and 
functional myocardial abnormalities identified in HTP contribute to the progression of myocardial 
dysfunction from an asymptomatic state to clinically apparent heart disease (de Leeuw and Kroon, 
1998). Considerable variability in the cardiac phenotype of HHD exists, with Black patients being 
more prone to concentric LVH (Kizer et al., 2004). Growing evidence suggests that systolic 
abnormalities in HT begin to develop in the early stages of the disease when global LV EF is still 
normal. The same mechanisms might be implicated in the progressive deterioration of LV systolic 
performance during the development of clinical HF (Vinch et al., 2005, Bountioukos et al., 2006, 
Yuda et al., 2002, Pela et al., 2001). Accordingly, functional abnormalities causing HF symptoms 
may be the long-term consequence of systolic functional deficits that are initially not detectable by 
conventional echocardiographic methods.  
 
The measurement of global LV function is the most common indication for echocardiography and 
LV dysfunction is known to be a strong prognostic marker of adverse outcome (Quiñones et al., 
2000), most frequently assessed by the calculation of EF by Modified Simpsons biplane method. 
This Modified Simpsons and other methods are heavily dependent on image quality, image 
orientation, and reader experience. Whereas global systolic LV function in HTP with HF is 
preserved according to standard LV EF assessment, a number of previous studies identified systolic 
LV abnormalities in a substantial portion of asymptomatic or mildly symptomatic HTP using 
advanced echocardiographic and MRI techniques (Vinch et al., 2005, Bountioukos et al., 2006, 
Yuda et al., 2002, Pela et al., 2001, Rosen et al., 2006, Palmon et al., 1994, Aurigemma et al., 
1995).  
 
The need for formal quantitative assessment of myocardial systolic function remains a significant 
challenge. STE is an innovative technique in assessing LV twist mechanics quantitatively 
identifying global and regional dysfunction in a multitude of cardiac conditions. Two dimensional 
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strain and LV twist is not angle-dependent and has been shown to correlate well with EF measured 
both by echocardiography (Belghiti et al., 2008, Delgado et al., 2008) and MRI (Brown et al., 2009, 
Cho et al., 2006). LV twist occur as result of the apex of the LV moving in a counter clockwise 
direction while the base moves in a clockwise direction in systole.  The resulting twist is thought to 
be pivotal in achieving a 60% reduction in LV volume despite only a 15% reduction in myocardial 
fibre shortening. Over and above the pattern of left ventricular geometric response to hypertension, 
abnormalities of cardiac mechanics based on LV twist mechanics may be important in 
understanding the pathogenesis of the transition from compensated to decompensated HF. 
 
LV hypertrophy is associated with a variety of alterations including: fibrosis, impaired coronary 
artery vasodilatory capacity, depressed LV wall mechanics, and abnormal LV diastolic filling 
pattern (Weber and Brilla, 1991, Querejeta et al., 2000, Conrad et al., 1995, Brilla et al., 1991, 
Martinez et al., 2003). It is well known that a preclinical systolic dysfunction occurs in HTP with 
LV hypertrophy (Mizuguchi et al., 2010b, Narayanan et al., 2009) but, in addition, an impairment 
of longitudinal systolic function is seen even in patients with normal LV geometry. In this respect, 
STE appears more sensitive than conventional echocardiography in identifying a reduction of 
intrinsic myocardial contractility, evident in HTP long before LV hypertrophy becomes detectable. 
These early changes of myocardial contractility may be secondary to hemodynamic and/or 
biochemical alterations. 
 
Our study documented a reduction in all strain parameters and increased LV twist in HTNEF. All 
patients with HTNEF had abnormal geometric patterns (85% LVH; 15% concentric remodelling). 
A reduction in LV LS with impairment in LV radial and CS in patients of NYHA III and IV 
functional class was found in 64 Caucasian patients with normal EF (Kosmala et al., 2008). The 
decline in LS with worsening HF precedes any other strain parameter and may be ascribed to the 
hypertension-associated damage of subendocardial myocardial fibres, which are mainly responsible 
for longitudinal function ((Kang et al., 2008, Kosmala et al., 2008). These fibres are more 
vulnerable to increased wall stress, stress-induced ischemia and microvascular dysfunction 
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accompanying hypertension. Furthermore, the impairment in radial and circumferential function, 
reflected by decreased respective strain values, appears later in the course of HHD and thereby 
postulated to contribute to global cardiac dysfunction (Kosmala et al., 2008). However, Palmon et 
al (Palmon et al., 1994) found that radial, circumferential, and LS appear to decline in parallel in 
hypertensive disease. Stanton et al (Stanton et al., 2009) speculated that LS < 12% could be 
recommended as diagnostic cut-off for LV dysfunction. There are discrepancies in myocardial 
strain abnormalities reported in HTP and this could be attributed to vendor variability, population 
diversity and variances in burden of disease.  
 
Regionally differing patterns of changes in morphology and deformation in the basal LV segments 
are determined by the fibre structure of the myocardium and its interaction with local wall stress. 
The sub-endocardial fibres are mainly longitudinally oriented, while mid-wall fibres are 
circumferential (Greenbaum et al., 1981). Local wall stress is determined by curvature, with a 
higher level of wall stress seen with an increasing radius of curvature. While in the apex, the radii 
of curvature are similar in all directions, at the base, they are substantially smaller in the radial 
compared to the longitudinal direction. Both fibre orientation and local geometry result in a non-
uniform wall stress distribution, with a decrease from endo- to epicardium and from equator to 
apex (Büchi et al., 1990, Hood Jr et al., 1969, Wong and Rautaharju, 1968). Due to a greater local 
radius of curvature, stress in basal segments will increase more than in mid and apical segments 
when LV pressure increases. Since hypertrophy is directly related to wall stress (Grossman et al., 
1975) there must be a gradual increase in the hypertrophic response from apex to base. 
 
In models of LV myocardial deformation, it has subsequently been shown that the LV myocardial 
fibre architecture is important for LV function (Arts et al., 1979, Ingels Jr, 1997). Adequate 
pressure generation is probably primarily produced via circumferential mid-wall fibres but also by 
subendocardial and subepicardial spiralling fibres that generate LV twist and shortening of the LV 
long axis (Ingels Jr, 1997). In previous work, it has been shown that LV twist is of fundamental 
importance to systolic LV function (Arts et al., 1979, Ingels Jr et al., 1989, Sengupta et al., 2008b, 
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Sengupta et al., 2006). LV twist may also be an important manner to equalize transmural 
differences in sarcomere shortening, end-systolic fibre stress, and contractile work during the 
ejection phase (Arts et al., 1979). The increased end-systolic wall stress, an expression of afterload, 
as well as the loading conditions, are likely to play a role in determining myocardial deformation 
dysfunction in HHD. The chronic increase of end systolic wall stress may promote subendocardial 
synthesis of collagen, thereby contributing to reduction of myocardial deformation. 
  
Various factors, not only those that are directly related to the increased LV wall stress, are involved 
in the deterioration of myocardial deformation in the course of hypertension (Kosmala et al., 2008). 
It is well known that in LV hypertrophy (Kosmala et al., 2008), myocardial fibrosis related to 
pressure overload appears frequently in the more vulnerable subendocardial layer. Increased left 
ventricular mass index, one of the principle pathophysiologic determinants of LV dysfunction in 
hypertension, was independently associated with impaired myocardial deformation assessed by 2D 
strain [longitudinal, radial, and circumferential] (Kosmala et al., 2008). The same holds true for the 
duration of hypertension with a greater extent of systolic dysfunction accompanying a longer 
disease history (Kosmala et al., 2008).  
 
It is well known that the net LV twist is the result of subepicardial contraction and subendocardial 
counterbalancing contraction (Ingels Jr et al., 1989). The epicardial fibres govern the direction of 
LV twist, mainly owing to their longer arm of movement. Therefore, it can be anticipated that the 
epicardial fibres may become even more dominant when the LV walls are thicker, in particular 
relative to LV cavity dimension, because in such walls the differences in the arms of movement 
will be greater. This may be due to the increased concentric hypertrophy leading to an increased 
lever arm for the epicardial fibres. In the normal LV, a counterclockwise-rotating torque in the 
subepicardium dominates a clockwise-rotating torque in the subendocardium, because the 
subepicardium fibres have a larger radius. An increase in relative wall thickness with hypertrophy 
will produce larger radius differences between endocardium and epicardium, resulting in an 
augmentation of peak twist.  
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Another mechanism is that reduced endocardial shortening may also lead to increased LV twist 
since the forces opposing twist are reduced. LVH impairs subendocardial perfusion with contractile 
dysfunction (Zhang et al., 1993, Lima et al., 1985, Johansson et al., 2008). The impairment of 
subendocardial myofibre shortening leads to a greater transmural shortening gradient, which is 
defined as epicardial minus endocardial myofibre shortening normalized to the mean value (Van 
der Toorn et al., 2002). Therefore, in patients with LV hypertrophy, transmural gradient of 
myofibre shortening may be greater resulting in an enhanced LV twist.  
 
In addition, the possible mechanisms for the relative lack of compensatory increase in BR to AR 
may be related to subendocardial ischemia as a result of oxygen supply /demand mismatch, 
microvascular dysfunction and altered capillary/myocyte ratio in the absence of epicardial coronary 
artery disease. Due to the larger radii, the torque of subepicardial fibres dominates and accounts for 
the enhanced counterclockwise rotation of the LV apex. Previous studies have found that in LV 
hypertrophy, AR and LV twist are augmented (Wang et al., 2007, Takeuchi et al., 2007a). In HTP, 
this could be a compensatory mechanism aimed at maintaining relatively normal LV systolic 
function (Przewlocka-Kosmala et al., 2006).  
 
However, we postulate that the LV dilatation after compensatory LV hypertrophy – a response to 
persistent pressure overload and augmented wall stress – is an important contributor to reduced 
myocardial deformation as a result of progressive deterioration of contractile function as the heart 
increases in size. Myocardial fibrosis is one of the factors responsible for myocardial function 
deterioration in hypertension (Komuro et al., 1991, Brilla et al., 1991). In HTP with normal EF, 
impaired LS and increased LV twist are directly related with serum levels of TIMP1, a marker of 
myocardial fibrosis (Martinez et al., 2003). This suggests that abnormal collagen turnover and 
myocardial fibrosis may contribute to early LV contractile dysfunction (Kang et al., 2008) with 
increasing collagen degradation contributing to greater systolic dysfunction. In the early stage the 
subendocardial longitudinal fibres are primarily affected so that unopposed epicardial torque will 
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increase apical twist, whereas later more widespread fibrosis or damage will affect global function 
and lead to reduced twist (Phan et al., 2009). It is likely that only transmural damage is associated 
with reduction of EF and twist, whereas subendocardial dysfunction (regional damage) results in 
myocardial strain impairment (Sengupta and Narula, 2008) and compensatory increase in LV twist. 
 
It is unclear whether increased LV twist is a compensatory response to maintain the intracavitary 
pressure or a secondary change of abnormal fibre structure caused by subendocardial dysfunction 
in HTP with normal EF. Early detection of the LV dysfunction, before development of LVH, may 
represent a clinical finding that would justify aggressive treatment aimed at reducing 
cardiovascular mobility and mortality. Prevention of LV remodelling favourably impacts the 
untoward natural history of HF, which may be, at least partly, related to the preservation of LV 
twist. Therefore, assessment of LV twist may be of importance in the evaluation and guidance of 
therapies in HHD, especially if these therapies are to influence cardiac remodelling. 
 
4.5 TWIST MECHANICS IN HYPERTENSIVE PATIENTS WITH LOW EF  
 
LV twist was decreased in HTLEF, with a reduction in AR and BR. All patients in the HTLEF 
group had LV hypertrophy (concentric and eccentric hypertrophy). The reduction in both AR and 
BR may imply that both areas are affected by a more global abnormality that affects both 
subendocardial and subepicardial fibres. AR correlated positively with degree of LV dysfunction, 
suggesting degree of apical dysfunction is more important in LV dysfunction than the degree of 
basal dysfunction. LV twist is directly correlated with left ventricular systolic function (Pacileo et 
al., 2011). Furthermore, LV twist or AR alone provides a more accurate quantification of LV 
contractility than does LVEF (Kim et al., 2009).   
 
Left ventricular AR represents the dominant contribution to LV twist. The mechanisms responsible 
for changes in twist dynamics are unclear, but might relate to LV dilatation, remodelling of cardiac 
myocytes and connective tissue matrix (Jin et al., 2007). The loss of LV twist is mainly due to a 
 
 
- 95 - 
 
decrease in counterclockwise AR. With the progression of the HHD, as a consequence of LV 
dilatation, the LV takes on a more spherical geometry and this advanced LV remodeling and the 
consequent loss of the oblique architecture of loop fibres, leads to impaired LV twist (Popescu et 
al., 2009). The differences in short-axis and long-axis dilatation result in changes in fibre angles 
that may further impair LV twist and thus cardiac function (Hutchins et al., 1978). 
 
 The progressive impairment of LV contractility and function involves not only the increase in LV 
dimensions and sphericity but also significant changes in the magnitude and pattern of LV rotation, 
especially RBR. In a recent study of patients with dilated cardiomyopathy (Popescu et al., 2009), 
RBR signified the expression of more advanced disease, with more severe LV remodelling, 
dyssynchrony, and systolic dysfunction compared to patients with normally directed AR. This 
study illustrates the intimate relationship between LV size, shape, and function: progressive LV 
dilation and increased sphericity leads to changes in myofibre orientation and LV twist mechanics 
with deterioration of systolic LV function.  
 
 
Normally, looking at the heart directly from the anterior wall, the LV fibre helix angle varies from 
the subendocardium to the subepicardium (Geerts et al., 2002, Ingels Jr, 1997). Previous 
mathematical models revealed the essential role of LV twist in optimizing LV oxygen demand and 
the efficiency of LV systolic thickening by uniformly distributing myofibre stress across the 
myocardial wall (Sengupta et al., 2008a). The transmural oxygen demand was found to be a 
function of the structure of the LV fibres, and the degree of the twist (Lumens et al., 2006). A wider 
fibre angle distribution is associated with a larger epicardium-endocardium (epi-endo) stress 
difference and is thus associated with a higher metabolic gradient (Lumens et al., 2006). The 
twisting motion of the LV reduces the sarcomeres length gradient and the metabolic gradient. 
Similarly, shorter endocardial sarcomeres decrease the endocardial sarcomere lengths and, hence, 
decrease the metabolic gradient (Lumens et al., 2006).  
 
 
 
- 96 - 
 
LV rotation or twisting motion has an important role in LV systolic function by generating 
maximum intracavitary pressures with minimum fibre shortening thereby reducing myocardial 
oxygen demand (Sengupta et al., 2008b). The endocardial layer consumes more oxygen than the 
epicardial layer, indicating that the endocardial sarcomeres develop high stresses at the beginning 
of systole, and then decrease toward end systole due to the shortening of the sarcomeres (Lumens et 
al., 2006). The epicardial outer layer shortens to a lesser extent than the inner layers, and maintains 
the stresses throughout the systole (Lumens et al., 2006). A higher endocardial oxygen demand 
corresponds linearly to higher mechanical stresses in the endocardium (Lumens et al., 2006). A 
significant impairment of LV twist will therefore result in increased myofibre stress and oxygen 
demand resulting in supply/demand imbalance. This low-efficiency state would further impair 
myocardial contractility, possibly representing the initial step of a vicious circle of progressive LV 
dilatation and decline in LV systolic function.  
 
However, factors that relate to remodelling such as neurohormonal and growth factors, cytokines, 
apoptosis etc. were not evaluated and may be an important determinant of remodelling and its 
subsequent effect on twist mechanics. Furthermore, increase in the size of the cardiomyocyte, 
alterations in the ECM, and abnormalities of the intramyocardial coronary vasculature may also 
contribute to abnormalities in twist mechanics. Moreover, other potential factors that may 
contribute to abnormalities of twist may relate to genetic abnormalities that may affect sarcomere 
function. 
 
Current data indicates that rotational deformation in HF patients is a more accurate marker of 
changes in cardiac muscle performance or predictor of outcome than conventional measures such 
as EF or stroke volume (Burns et al., 2008, Sengupta et al., 2008b, Esch and Warburton, 2009, 
Sanderson, 2008). However, it is difficult to determine which occurs first: the decline in LV twist, 
which results in impaired systolic function and greater adverse remodelling, or adverse pathological 
remodelling resulting in a decrement of LV twist in HTP. We believe the association of RBR 
especially in a clockwise direction represents a novel assessment of more severe LV remodelling in 
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HTP with left ventricular systolic dysfunction in the absence of ischemia. The loss of LV twist may 
result in further decline in LV function and initiate a continuous, vicious cycle of remodeling. This 
raises the question whether RBR represents a more advanced state of remodeling or if it is the 
precipitant to the development of more advanced remodeling. 
 
4.6 RELATIONSHIP BETWEEN BIOMARKERS OF COLLAGEN DEGRADATION AND 
LV TWIST IN HYPERTENSION INDUCED HEART FAILURE 
 
LV dysfunction, irrespective of the cause of HF, leads to perturbed wall stress resulting in 
remodelling and HF progression. Although it is known that remodelling of the myocardial ECM 
occurs in HF, a consensus on the nature of these alterations does not exist, with some evidence 
favouring fibrosis at the point of end-stage HF (Conrad et al., 1995, Weber et al., 1989, Querejeta 
et al., 2004), and others depicting collagen depletion (Spinale et al., 1998, Spinale et al., 1996, 
Dell'italia et al., 1997). MMPs are the key enzymes responsible for ECM degradation whereas the 
TIMPs endogenously inhibit this process. The interplay and balance of MMPs and their tissue 
inhibitors (TIMPs) determine the maintenance of interstitial tissue homeostasis. The collagen 
network (collagen associated with groups of cardiomyocytes or perimysium, and collagen which 
surrounds and interconnects individual cardiomyocytes or endomysium) is responsible for 
providing the supportive scaffolding for cardiomyocytes, but also serves to integrate the individual 
contractions of these cells and provide a coordinated delivery of force (pressure) to the left 
ventricular chamber for expulsion of blood (Weber et al., 1994). 
 
Some recent  observations suggest that the ratio between MMPs and TIMPs, which is an indirect 
measure of MMP activity, may serve as a biomarker of LV remodeling (López et al., 2010). 
Circulating MMP1:TIMP1 ratio has been shown to be a biomarker of collagen degradation (López 
et al., 2006). Serum MMP1:TIMP1 ratio is associated with the degradation and loss of endomysial 
and perimysial collagen (González et al., 2009). Excess of MMP1 relative to TIMP1 is present in 
the myocardium of low EF HTP  compared with preserved EF HTP (López et al., 2006). The up-
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regulated expression of MMP1 is detected at both the cardiomyocyte and the interstitial level in 
HTP with low EF. Several studies have delineated the relationship between MMPs and TIMPs, and 
that the changes in the MMP1:TIMP1 ratio correlate with LVH and dilation (López et al., 2006, 
Lindsay et al., 2002, González et al., 2010, González et al., 2009, López et al., 2004, López et al., 
2010, Kang et al., 2008).  
 
This study revealed that in HTP with preserved EF, LV twist is increased while LV twist is 
diminished in HTP with low EF who initially present with HF. This suggests LV twist varies with 
the degree of remodelling and systolic function caused by hypertension. Moreover, circulating 
biomarkers of collagen are elevated to a greater degree – with decrements in myocardial 
deformation – in HTP with low EF compared to those with normal EF. Additionally, an inverse 
relationship between MMP1:TIMP1 ratio and LV twist even when adjusting for EF was noted; 
implying that the decline in LV twist may be related to the remodelling process of the ECM. HTP 
with normal EF have lower MMP1:TIMP1 ratios, suggesting less extracellular remodelling that 
does not affect all regions of the myocardium to the same extent. Prior studies have suggested the 
major pathophysiological abnormality in HTNEF patients is that of subendocardial ischemia (Fujii 
et al., 1992), which occurs in the absence of coronary disease and initially affects subendocardial 
fibres (Kang et al., 2008). Subendocardial ischemia results from diminished coronary flow 
autoregulation in the subendocardium compared to the subepicardium with increased transmural 
pressure loss within the microvasculature contributing to subendocardial underperfusion and 
vulnerability to ischemic injury (Fujii et al., 1992). 
 
In HTP with normal EF, the degree and location of collagen degradation may relate to the 
myocardial deformation indices, i.e. interstitial and perivascular fibrosis and collagen degradation 
is likely to initially affect the subendocardial fibres in the presence of subendocardial ischemia 
(Kang et al., 2008), with decrement in LS due to their prominent subendocardial location (Kang et 
al., 2008), and thereafter the development of circular fibre dysfunction in the midwall (decreases in 
radial and CS) (Kang et al., 2008). If the greatest area of involvement is the subendocardium and 
 
 
- 99 - 
 
perhaps some degree of involvement in the midmyocardium, then LS will be most affected with 
varying decrements of circumferential and RS noted. Subendocardial fibre dysfunction will cause 
less opposition to the subepicardial fibres, thus the predominant rotatory effects of the 
subepicardial fibres dominate during systole and result in enhanced BR, AR and net LV twist. In 
our study, this postulate would explain the strain, AR and net LV twist observed in HTNEF. A 
nonsignificant trend of increased BR also was noted. 
 
Higher MMP1:TIMP1 ratio was detected in HTP with low EF compared with HTNEF patients 
suggesting that this process is characterized by more extensive extracellular remodelling. We 
propose that perhaps this adverse remodelling is a more diffuse process that affects all regions of 
the myocardium to a similar degree, such that the relatively preserved subepicardial fibre function 
seen in HTNEF is abolished, resulting in impairment of all myocardial strain and LV twist. As 
collagen degradation increases, there is global dysfunction of both the subendocardial and 
subepicardial fibres, with diffuse collagen degradation in subepicardial and subendocardial fibres 
resulting in greater impairment in AR and LV twist. This accompanies greater decrements in strain 
parameters in HTP with low EF. 
 
The decline in LV twist may relate both to factors that cause a global reduction in systolic function 
and specific remodelling factors that decrease LV twist. The loss or disruption of this collagen 
network may compromise systolic function by three mechanisms. Firstly, the loss of mysial 
collagen results in discontinuity of the ECM, compromising the alignment and support of the 
matrix (López et al., 2006). A second factor relates to the possible loss of synchronized sarcomere 
contraction (López et al., 2006). The final mechanism occurs as a consequence of increased MMP1 
activity where there is myocardial slippage and, consequently, a decreased number of muscle layers 
in the left ventricle (López et al., 2006). Collagen loss promotes myocyte slippage, thereby altering 
LV structure and function with ventricular dilatation, increasing LV sphericity and greater systolic 
dysfunction if the process is exaggerated (Laviades et al., 1998, Li et al., 1998, Timms et al., 2002, 
Thomas et al., 1998, López et al., 2006). The loss of the oblique architecture of loop fibres and 
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abnormal muscle fibre orientation (Popescu et al., 2009) responsible for the wringing motion 
results in a decline in LV twist (van Dalen et al., 2010). 
 
However, despite the available information on these biomarkers in HTP, a number of major issues 
remain that limit their clinical usefulness. In fact, based on current knowledge, it is not possible to 
determine prognostic, diagnostic, or predictive cut-off values for hypertensive cardiovascular 
damage. Although several studies show cut-off values, these values were not used in a prospective 
way. Moreover, although non-invasive identification of increased collagen turnover may be 
possible with evolving cardiac magnetic resonance and molecular techniques, they still require 
further investigation. Another major limitation in the field of collagen biomarkers is the lack of 
systematic meta-analysis of the multiple clinical studies published in order to both analyse the 
discrepancies in the results among different studies and identify reproducible patterns of alterations 
in the biomarkers.  
 
4.7 LIMITATIONS 
 
2D STE has the advantages of ease of application and analysis and good data reproducibility. 
However, the accuracy of the measurements largely depends on the image quality and the accuracy 
of tracking. 2D myocardial deformation analysis generally requires higher quality images than 
standard 2D and Doppler echocardiography. The analysis of the LS of the lateral and anterior walls, 
and the basal circumferential and RS of the posterior basal segments are technically more 
challenging than other segments, presumably due to the suboptimal image quality as a result of rib 
artefacts or proximity to non-myocardial structures such as the posterior mitral annulus. In 
particular, suboptimal image quality of basal LV short-axis recordings is a challenge because of 
acoustic problems related to the depth and the wide sector angle needed to visualize the entire LV 
base, and out-of-plane motion, when the base descends toward the apex in systole (Opdahl et al., 
2008). Furthermore, the imaged epicardium is sometimes too bright, causing signal saturation, 
which precludes discrimination of the subtleties of image contrast that allows speckle tracking to 
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work (Van Dalen et al., 2009). The size of a tracking point is in reality larger as the one that is 
displayed (Van Dalen et al., 2009). Therefore, placement of a tracking point in the epicardium can 
potentially result in stationary artefacts by tracking of non-moving speckles outside the heart (Van 
Dalen et al., 2009). Motion of the mitral valve leaflets in the area of tracking points placed on the 
endocardium will potentially interfere with proper speckle tracking as well (Van Dalen et al., 
2009). Finally, and probably most importantly, in a significant number of patients, true AR will be 
underestimated to a variable extent because of inability to visualize the true LV apex (Van Dalen et 
al., 2009). The short axis recordings and analyses should be done meticulously (Van Dalen et al., 
2009). Currently, the anatomical landmarks are to loosely defined and in particular attention should 
be made to record the correct cross-section at the LV apical level (Van Dalen et al., 2009).  
 
4.8 FUTURE RESEARCH 
 
Vendor diversity of currently available speckle tracking software requires investigation to 
determine whether quantitative values obtained from every system are similar. The lack of 
standardization of imaging planes and different speckle-tracking algorithms among vendors make it 
difficult to make comparisons or establish normal values for LV twist with high levels of 
confidence. A multicenter study in a large number of normal subjects with different ultrasound 
machines is required to resolve this issue. The lack of agreement between equipment and 
proprietary software preventing the adoption of universally accepted thresholds of abnormality. 
Given differences in image processing and the information used to derive a final strain value 
among manufacturers, follow-up echocardiography for strain analysis using a different 
manufacturer’s system may provide misleading results. In a recent expert consensus statement from 
the American Society of Echocardiography and the European Society of Echocardiography, a 
recommendation was made that more comparisons between vendor-specific software packages 
must be made before STE can become routinely adopted in clinical practice (Mor-Avi et al., 2011). 
Most reports evaluating differences between STE vendors report data analyzed from the images 
directly using echocardiographic equipment and software from the same manufacturer (Manovel et 
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al., 2010, Biaggi et al., 2011, Sun et al., 2012b, Koopman et al., 2010). The limitation of applying 
these studies to clinical practice is that many echocardiography labs use equipment from multiple 
vendors for image acquisition and may have STE software from one or more vendors. Furthermore, 
many echocardiographic labs store images in a neutral imaging format, necessitating the use of 
STE programs that analyze vendor-neutral images for patient follow-up.  
 
Therefore, what remains to be resolved is to what extent such differences are clinically relevant. 
Caution is therefore advised when trying to generalize results between current competing STE 
vendors. Moreover, population samples representing diseases affecting cardiac function should be 
studied to determine the diagnostic power and abnormal ranges of LV twist values. Clinically, until 
standardization is achieved, echocardiography labs should identify lab-specific normal values with 
each vendor analysis package and use the same software in serial studies. Most studies, however, 
have been limited to images acquired by a single ultrasound machine manufacturer using the same 
vendor-specific analytic tool. Although appropriate for early research applications, the use of a 
single vendor is impractical because it prevents widespread prospective or retrospective clinical or 
research applications in large populations across multiple imaging platforms, software packages, 
and institutions. 
 
Three-dimensional STE is a new technique that provides information regarding different 
parameters of LV myocardial deformation (Pérez de Isla et al., 2008) with a better assessment of 
regional myocardial mechanics, which might be important for diagnosis, prognosis, and therapy. 
3D STE is likely to allow standardization of LV planes used for assessing twist measurements. 
However, currently available 3D speckle tracking echocardiographic methods are based on 
different algorithms, which introduce substantial differences between them making them not 
interchangeable with each other. Therefore, it is critical that each 3D speckle-tracking 
echocardiographic method is validated individually before being introduced into clinical practice.  
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Identifying subclinical left ventricular (LV) systolic dysfunction among hypertensive subjects 
might be helpful in identifying patients at higher risk for HF. Given the prevalence of hypertension 
in the population, identifying patients at high risk for HF might permit targeted preventive 
strategies. STE allows comprehensive assessment of myocardial function and the spectrum of 
potential clinical applications is actually expansive. In particular, a growing body of evidence 
suggests that the assessment of LV twisting is feasible and useful in several clinical settings. The 
relationship between strain and twist mechanics of the LV provides insight into the transmural 
heterogeneity in myocardial contractile function. The presence of a subendocardial- to-
subepicardial gradient in LV mechanics may provide a useful clinical measure for early recognition 
of a subclinical state that is likely to progress into systolic HF. So LV twisting dynamics appears 
useful in detecting early LV dysfunction in the setting of systemic diseases with cardiac 
involvement such as arterial hypertension.  
 
The pathway from hypertension with normal or increased twist with preserved EF to that of 
diminished twist in HTLEF may not be unidirectional. Further prospective research is warranted in 
assessing whether patients with HTLEF and normal patterns of twist develop clockwise AR during 
progression of LV remodelling. Moreover, further research is needed to determine if more adverse 
clinical sequelae will occur in patients with RBR. Furthermore, the impact of drug therapy is 
unknown in patients with HTLEF i.e. do some patients exhibit reverse remodelling and 
normalisation of twist mechanics on good medical therapy. However, whether a strategy tailored to 
normalise LV twist provides additional clinical benefit compared with HF controlled to 
conventional targets is uncertain. In addition, research is required to assess whether patients with 
RBR have a longer duration of congestive cardiac failure or a shorter duration of adequately treated 
HF.   
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4.9 CONCLUSION 
 
This study established normative data and patterns for myocardial deformation (strain and LV 
twist) in a normal black-African adult population across different age groups and can be used as a 
baseline for future studies. Age was the major determinant of increased LV twist in a normal black 
population. LV twist may be a compensatory mechanism to preserve EF and maintain normal 
systolic function with advancing age and in hypertension. LV twist varies with the degree of 
remodeling and systolic function in hypertension. RBR represents a novel assessment of more 
severe LV remodeling and LV systolic dysfunction in hypertensive patients. Alterations in collagen 
turnover not only accompanies more adverse remodelling but also contributes to LV twist 
differences observed between HTLEF and HTNEF patients. The inverse relation between LV twist 
and loss of myocardial collagen scaffolding suggests that integrity of the extracellular matrix may 
play an important role in preservation of LV twist.  These findings highlight the value of LV twist 
as a sensitive global parameter of LV systolic myocardial performance. Its impairment possibly 
plays an important role in the development of LV remodelling. LV twist may provide significant 
value over clinical and echocardiographic features in predicting LV remodelling. Accordingly, 
longitudinal studies assessing LV twist may provide significant value in clinical practice as an early 
marker for risk stratification in hypertensive patients who may benefit from aggressive medical 
therapy to prevent LV remodelling and heart failure, and poor outcomes. 
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APPENDIX c - Time to twist: marker of systolic dysfunction in Africans with hypertension 
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APPENDIX d - Relationship between Left Ventricular Twist and Circulating Biomarkers of 
Collagen Turnover in Hypertensive Patients with Heart Failure 
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